Archives: CannabisNewsWire

On Tuesday this week, the New York City Council passed two cannabis-related resolutions as part of a package of marijuana laws that the progressive-minded caucus of the chamber wants to see enacted.

One of those resolutions calls on the Administration of Children’s Services (ACS) to adopt a new policy to the effect that finding someone using or in possession of marijuana shouldn’t in itself mean that a child is in danger and should be removed from that person.

Child custody issues constitute one of the most serious yet overlooked consequences of cannabis consumption, even in places where the drug has been legalized for either recreational or medical use.

The City Council’s resolution details how there is a racial disparity in the way marijuana possession arrests are done, and also points out that the ACS doesn’t immediately conclude that a child is at risk of harm just because a parent or caregiver takes alcohol. This same principle should apply in the case of marijuana consumption, the council argues.

The second measure is addressed to the state legislature. It requests the lawmakers to enact legislation mandating the Department of Health in New York State to formulate hospital drugs testing guidelines or regulations for pregnant women and those giving birth. Those regulations should include provisions on informing hospital patients about their rights if matters of drug testing and drug use are to be discussed.

The current practice is that as soon as a pregnant woman tests positive for any drug, including cannabis, the hospital reports this to the Statewide Central Register of Child Abuse and Maltreatment. On the basis of that report, ACS launches an investigation into the matter.

The NYC Council notes in its resolution that while it isn’t clear how hospitals enforce their drug testing policies, people of color and those from impoverished communities seem to be particularly targeted.

Additionally, the resolution notes that there is still limited research regarding the effects of marijuana use during pregnancy. However, even that limited research doesn’t show that cannabis use is on its own a risk factor for serious neonatal problems.

The lack of clarity on the drug testing policies of hospitals means that pregnant women often volunteer information about their drug use not knowing that such information could result in child welfare issues.

Having a clear drug testing policy would encourage women to be free about disclosing their drug use habits since they will not have any fear that child welfare cases will be instituted simply because those women tested positive for marijuana, the councilors reason.

These resolutions show how keen the city council is to see marijuana reform implemented. Earlier in April, they also passed a resolution to put an end to pre-employment marijuana testing. This takes effect next year.

It remains to be seen whether the state legislature will act upon the well-intentioned resolution on hospital drug testing, but pundits believe that the entire cannabis industry, including industry players like ChineseInvestors.com Inc. (OTCQB: CIIX) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF), will be rooting for a positive outcome so that women stop being unfairly victimized for using cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Lowell Farms: A Cannabis Café is set to become the first marijuana café to open its doors to the public if its launch on September 1 this year goes according to plan. The West Hollywood Business License Commission gave the new business its final approval by a unanimous decision during a meeting that was held on July 16.

Andrea Drummer, the Head Chef of the café, said that they are proud to be the first in the U.S. to open a cannabis café. Drummer added that they take that responsibility highly, since it will set the pace for the educational and responsible use of marijuana as a food ingredient.

Drummer, a longtime cannabis advocate has authored a marijuana cookbook titled “Cannabis Cuisine: The Art of Cooking with Marijuana.” She has also served as a private chef to several celebrities, including Whiz Khalifa and Miguel. Andrea Drummer has also appeared on a number of television shows showcasing how people can cook with marijuana. These include “Cooking on High” on Netflix and Chelsea On!

The menu of the café, which will include CBD and THC-infused edibles, was designed by Drummer.

The café will have an area designated for people who don’t smoke cannabis and another area for those who smoke the drug. In the smoking area, a tableside service featuring unique strains grown by the company, will be available. A “Flower host” will be in charge of offering this service.

This “flower host” will explain the flavor profiles and specific effects of the different strains on offer before helping patrons to roll a joint. Dabs and bongs will also be available.

Representatives of the café also revealed that the establishment will have an advanced air filtration system in order to respect the interests of people in the neighborhood who may object to the cannabis smells wafting from the café.

The value of this filtration system took on greater importance when it emerged that the rabbi of a nearby synagogue had written to the license commission objecting to the planned location of the cannabis café.

The café is also taking the added precaution of planting landscaping that has been proven to absorb odors and purify air. Digital renderings of this landscaping were released to show that the café is taking every possible step to limit the impact of the establishment upon those in the neighborhood.

Drummer disclosed that the café idea has been fine-tuned over a period of four years and it was a logical next step after the push to have marijuana legalized was attained.  Industry watchers believe that the entire industry, including Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS), will be thrilled when this café opens since it will be another step towards making cannabis a mainstream substance.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The registered medical marijuana caregivers in Michigan are authorized to grow more than a million cannabis plants, according to state statistics. This information is crucial as the state transitions from a purely medical cannabis program to one that embraces the recreational use of the drug by adults.

Even if the state accelerates the process by which new commercial growers are licensed, it is unlikely that any of those licensees will have harvested, processed and distributed their marijuana crop at the time recreational sales are launched.

In August 2017, Andrew Brisbo, the Director of the Bureau of Medical Marijuana Regulation stated that approximately 43,000 patients had nominated a caregiver to grow a maximum of 12 cannabis plants for the medical use of the patient.

That statistic means that approximately 1.14 million marijuana plants are under the direct control of the registered caregivers in the state.

Currently, the number of caregivers on the medical marijuana program has risen to an estimated 47,000. This could mean that nearly 1.5 million cannabis plants are grown by these caregivers.

To put this figure in context, the 78 commercial cultivators with state-issued licenses have a 108,000 plant cultivation limit.

All the existing large scale growers and the caregivers currently supply the medical marijuana market whose current patient population stands at 300,000 (Michigan has the second strongest medical marijuana market in the country).

If recreational users come on board, the number of medical marijuana patients will be dwarfed by the number of adults who use cannabis recreationally. Statistics suggest that at least 1.54 million Michigan adults have used recreational marijuana at some point in their lives, so once recreational sales begin, the number of recreational users is likely to be five times that of medical marijuana users.

This means that Michigan could face the same supply shortages that have been witnessed in the states that transition from just medical marijuana markets to recreational cannabis as well. Such supply shortages normally trigger a frenzied expansion of cultivation capacity, which in turn causes a glut once all that extra marijuana finally enters the market.

To prevent the nosedive in prices which results from the glut, Michigan would be well advised to incorporate the caregiver-grown marijuana in the recreational market as well so that the recreational market is kept stable during its first months. This shouldn’t present any quality issues since the caregivers have been supplying the medical cannabis market of the state for years.

Analysts hope that the cannabis industry’s major players in Michigan and elsewhere, such as Youngevity International Inc. (NASDAQ: YGYI) and Willow Biosciences Corp. (CSE: WLLW), will welcome the caregivers whose role provides all-round benefits to all concerned.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A recent study shows that cannabis extracts can impair the survival of some types of cancer cells and also inhibit their spread. However, the effects of the cannabis extracts vary according to the chemical profile of the extracts used, the researchers discovered.

The team of researchers found that the results of using just one compound of cannabis, such as THC, to kill cancer cells wasn’t as promising as using full-spectrum cannabis extracts. Since marijuana has hundreds of compounds whose concentration varies from one preparation or marijuana strain to another, it was difficult to determine which particular combination of compounds had the most significant therapeutic effect.

The team, whose findings were published in Oncotarget, a journal centered on cancer research, show that 12 cannabis extracts having varying phytocannabinoid profiles were tested on 12 different human cancer lines.

Each of the 12 cancer cell samples was treated using increasing doses of different marijuana extracts over a 24-hour duration. Of the 12 cannabis extracts, five were especially effective in acting on a variety of cancer types. Nevertheless, the researchers found that different cancers seemed to respond to different marijuana extracts even if those cancers originated from the same body organ.

For example, two forms of prostate cancer cells were most responsive to different cannabis extract formulations and yet it would be expected that the same formulation would work for these two cancers since they all affect the prostate gland.

The marijuana extracts also exhibited different levels of effectiveness in terms of shrinking cancer cells. Out of the 12 preparations, only three were able to shrink cells by up to 51 percent of their baseline (original) size.

Some of the common attributes shared by the extracts which showed higher levels of effectiveness included their higher concentration of THC and the larger variety of phytocannabinoids which have been decarboxylated.

The researchers concluded that the therapeutic action of marijuana extracts on cancer cells cannot be attributed to a single compound, but rather to the synergy of different compounds acting together.

They also added that the fact that cancers from the same line react differently to cannabis extracts means that other compounds, apart from THC, work together to produce a pharmacological effect upon the cancer cells.

The team of researchers therefore called for more research to be done about the way cancer cells respond to cannabis. For example, more information is needed regarding the effect of the presence or absence of cannabis receptors on cancer cells when treating those cancers using marijuana extracts.

Marijuana industry pundits think that industry participants like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and VPR Brands LP (OTC: VPRB), will feel vindicated that the industry’s assertion regarding the therapeutic effects of marijuana is starting to be proved by independent researchers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The U.S. Food and Drug Administration (FDA) started receiving comments on CBD regulation from the public and other stakeholders in April and the comments period came to an end early last week.

The agency had initially planned to close the comments period on July 2 but the overwhelming public interest in the matter led the FDA to extent that deadline to July 16. By the close of the comments period, more than 4,400 submissions had been filed by individuals and organization.

The comments received covered everything imaginable about the therapeutic effects of CBD, how the compound should be tested, packaged and marketed, as well as matters of consumer protection and law enforcement.

There were hundreds of comments from individuals who claimed that CBD had helped them to deal with the symptoms of different health challenges, such as pain and anxiety. Other people claimed that they were able to wean themselves off of other drugs that had serious side effects by using CBD.

Several health associations and medical professionals submitted comments to the effect that the agency should regulate CBD as a health supplement as long as strict labeling and quality standards are set for manufacturers.

The Dravet Syndrome Foundation submitted a comment urging the FDA to formulate regulations that standardize the labeling of CBD supplements on matters of concentration, stability and the ingredients in the products since Dravet syndrome sufferers have been turning to these products after failing to get relief from the existing remedies.

A group of 37 state attorneys general also wrote to the FDA asking the agency to formulate rules that would protect consumers by requiring manufacturers to provide accurate information about the risks and potential benefits of CBD products. This would enable consumers to make an informed decision about the CBD products they use.

The Center for Science in the Public Interest (CSPI) submitted their comment requesting the FDA to design a program through which the state laws on CBD and other related products could be gradually aligned with the federal regulations on these products. By bringing uniformity to the CBD rules across different jurisdictions, the FDA will have taken a significant step towards safeguarding consumers from adulterated, mislabeled and contaminated CBD products, CSPI added.

The National Association of State Departments of Agriculture (NASDA) called on the FDA to work closely with them in order to find ways to regulate the industry without stifling its growth.

The FDA will use these comments, along with any other input it receives from other fora, such as a planned hemp conference next month, while formulating the draft rules for the hemp industry which are slated to be released in August.

Marijuana industry analysts believe that players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8), will be eager to see what rules are finally released since CBD products could be an additional moneymaker for these entities.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A coalition of more than a hundred cannabis companies and industry groups has sent a letter to Congress urging lawmakers to include social equity in any legislation that is proposed as a way of ending marijuana prohibition.

The letter, sent on Thursday last week, asserts that the work of Congress will be incomplete if they only stopped at legalizing marijuana without going further to address issues of social equity.

More specifically, the groups and associations that signed this letter express concern that the people who were worst affected by the War on Drugs are likely to be left behind as the marijuana industry takes off because those individuals who have a past conviction for marijuana-related charges are explicitly barred from participating in the legal marijuana industry in the states where marijuana is legal. These individuals are also unable to raise the capital needed to participate meaningfully in what the signees called “the new green rush.”

The letter states that in 2018, the sale of recreational and medical marijuana in the states that approved marijuana generated $10.4 billion, and $1.2 billion went to state governments in the form of taxes. Additionally, more than 200,000 people have jobs in the legal cannabis industry, but a significant proportion of people from the communities which were disproportionately affected by the prohibitionist laws are staying behind due to the constraints they face.

The coalition proposes a number of suggestions that Congress can consider in order to right the wrongs done during the War on Drugs.

For example, the letter suggests that in addition to descheduling marijuana at the federal level, Congress should pass a law allowing banks to service cannabis businesses without any fear of federal action against them.

The coalition also recommends that Congress should appropriate funds towards a social equity program so that the individuals and communities who suffered the most during prohibition can be facilitated or supported to take part in the legal cannabis industry across the country.

Another recommendation is that the criminal records of people on charges related to marijuana should be expunged so that those people no longer suffer the collateral consequences of those convictions.

4Front Ventures led the effort to write this letter. Other signees included Marijuana Policy Project, Michigan Cannabis Industry Association, MJ Freeway, Minority Cannabis Business Association, Americans for Safe Access, National Cannabis Industry Association (NCIA), and Berkeley Patients Group, among others.

This letter comes soon after another coalition of drug reform and civil rights groups also wrote to Congress making suggestions regarding how marijuana justice could be realized in any law that is passed to end cannabis prohibition.

Pundits believe that the marijuana industry, including companies like Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF), will be hoping that Congress uses the recommendations made by the different groups that have written to it when debating a comprehensive marijuana policy reform law.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

East of Eden Cannabis Company, a state-licensed marijuana company in California, has filed a lawsuit against Santa Cruz County accusing the local government for violating the rights granted to the company by the state government.

The company asserts that the state law allowing companies to deliver marijuana to any part of the state, including areas that opted out of hosting marijuana businesses, is being trampled upon by the enforcement of the rules passed by the authorities in Santa Cruz banning the delivery of marijuana into their jurisdictions.

This lawsuit is the second on the controversy surrounding who should have the upper hand in determining where legal marijuana can be distributed within the state of California.

In its court papers filed with the Superior Court in Santa Cruz, the marijuana company argues that the county has threatened to initiate a criminal investigation against East of Eden and also seek to have its state license revoked for making marijuana deliveries in areas that don’t permit marijuana within their jurisdictions.

The company therefore requests the court to give it permission to resume making cannabis deliveries and also declare the rules of Santa Cruz on the matter as “void and unenforceable.”

In January this year, marijuana industry regulators in the state okayed a rule that would permit licensed marijuana companies to start making cannabis deliveries anywhere in the state, including in jurisdictions that had passed ordinances banning marijuana businesses.

This new rule drew the wrath of anti-cannabis groups who said that the state was reversing the promise made by the voter measure which stated that local authorities would have the liberty to either accept or ban marijuana companies from operating within their jurisdictions.

Police chiefs and the League of California Cities have voiced concerns that unrestricted home deliveries of marijuana pose a risk that a lot of marijuana transactions will go unreported and pave way for the black market to thrive.

Santa Cruz County, Beverly Hills and close to twenty other local authorities took the added step of suing the state government and marijuana regulators in order to have the home delivery rule reversed.

The conflict between the state and local the authorities has prevented the marijuana industry from reaching its full potential in the largest (so far) single cannabis market across the world. Industry watchers believe that the entire cannabis industry, including participants like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Sugarmade Inc. (OTCQB: SGMD), will be following these legal battles closely because the decision of the courts could change the trajectory of the industry in all the states where marijuana is legal.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Department of Agriculture and Food in Utah has announced that it has selected eight applicants who will receive medical marijuana cultivation licenses as the state marches towards the implementation of a decision that voters approved during the elections last year but legislators later modified the ballot measure in what was called a compromise law.

The selected medical marijuana cultivation license applicants are Dragonfly Greenhouse, Oakbridge Greenhouses, Harvest of Utah, Standard Wellness Utah, Tryke Companies Utah, True North of Utah, Wholesome Ag, and Zion Cultivars.

The government’s statement unveiling the eight companies revealed that four of those eight companies have been operating in the state (conducting other business) while the other four had ties to Utah even if they were from outside the state.

In accordance with federal law, all the cultivation facilities will be located within Utah and all but one of the licensees will locate their grow facility in a rural part of the state.

The Department of Agriculture and Food spent hundreds of hours scrutinizing the 81 applicants who had expressed interest in growing medical marijuana in the state. The decision to select only eight growers, instead of the ten allowed by law, was made in order to avert a situation in which the supply of medical marijuana products would exceed the demand for those products. The eight growers were sufficient to create healthy competition and variety in the product offerings.

The chosen growers now have to undergo background checks before they are awarded the licenses.

Among other requirements, the application process required interested companies to have at least $250,000 to cover any issues that could arise while the company was growing medical marijuana in the state.

The licensed companies will be tasked with meeting the medical marijuana demand of approximately 42,000 patients that may enroll on the medical marijuana program during its first four years of existence. This number was arrived at after the University of Utah conducted a study to estimate the likely beneficiaries of the program.

Under Utah law, the cultivators who choose to grow marijuana indoors will be restricted to a maximum of 100,000 square feet of grow space while those who opt to grow the crop outdoors will be allowed to use a maximum of four acres. Depending on the spacing used, an acre can accommodate anywhere from 1,500 to 3,000 cannabis plants.

The law passed by legislators just days after the provisions of the ballot measure approved by voters took effect in December 2018 removed the permission that had been given to certain categories of patients to grow a maximum of six plants.

Under Prop 2, people living beyond a defined minimum distance from a medical marijuana dispensary would be permitted to grow their own medical marijuana. This provision was vehemently opposed by different groups, such as law enforcement, and it was removed by a law passed during a special session of the legislature.

Now that cultivators have been selected, industry analysts believe that the entire industry, including players like Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING), will be pleased that qualified patients could soon be able to treat their ailments using medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space.

Savvy companies such as Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary Khrysos Industries Inc. just signed a five-year contract to purchase hemp plant biomass for extraction, end-to-end processing and production of hemp-derived products. Indiva Limited (TSX.V: NDVA) (OTCQX: NDVAF) has successfully received an amended license from Health Canada for three additional grow rooms and three additional processing rooms. Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT) recently announced that its wholly owned subsidiary received a notification letter from Health Canada indicating that all requested license amendments have been approved. Other cannabis companies are making strategic moves in the industry as well. CannaRoyalty Corporation (CSE: OH) (OTCQX: ORHOF) has obtained final approval to move forward with its plan of arrangement with Cresco Labs, which will result in the largest-ever public company acquisition in the U.S. cannabis sector. And KushCo Holdings Inc. (OTCQX: KSHB) has partnered with C.A. Fortune, a leading full-service national consumer products sales and marketing agency, with the intent to grant viable CBD companies access to large-scale, conventional retail channels.

To view the full editorial, visit http://cnw.fm/Mwt1t

To hear the CannabisNewsAudio version, visit http://cnw.fm/da6zC

About Youngevity International Inc.

Youngevity International is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual main atreet of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution(R) Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

New data released by Nielsen shows that people who live in states where marijuana is legal snack more than their counterparts in states with prohibitionist laws. The uptick in the sales of snacks was noticed for sweet and well as salty snacks.

This study suggests that legalizing recreational marijuana can create a boom for the confectionary and snack segments of the food and beverage industry in the U.S.

While snacks sales saw a modest 6 percent increase in states where marijuana is still prohibited for recreational use, states that tolerate adult-use marijuana registered an increase of 7.2 percent in the sale of snacks.

In total, candy sales generated approximately $6.5 billion during the period under review. For this item alone, an increase of 2 percent was observed in states with legal recreational marijuana while those without these laws saw a modest 1.3 increase in the sale of candy.

It appears that salty snacks are the preferred option for cannabis users who get the munchies because the states where adult-use marijuana is legal generated $30 billion from the sale of salty snacks alone.

Nielson used this data to assert that no other single factor was responsible for the difference in the sales of snacks in the states where recreational cannabis is legal.

This claim may be credible because there is ample anecdotal and scientific evidence proving that consuming marijuana boosts one’s appetite and enjoyment of food. The data collected by the census divisions of the U.S. federal government also points to the fact that people get the munchies in states where recreational-use marijuana has been legalized.

Currently, 11 states and Washington, D.C. have legalized recreational cannabis while more than half of the union has given the nod to medical marijuana. Each round of elections now appears to bring more states on board either for recreational or medical marijuana, so the entire country could soon have legal marijuana in some form.

However, the federal government still maintains cannabis as a Schedule I drug although recent events, such as the congressional subcommittee hearing on how to end prohibition may suggest that the federal government could soon revise its position on marijuana.

Analysts posit that players in the cannabis industry, such as Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), will not regard the findings of this study as anything new since the industry has known for long that cannabis has a positive effect on those with poor appetite.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Michigan has unveiled the details of the communities that will benefit from the marijuana Social Equity Program of the state. The MRA (Marijuana Regulatory Authority) made this announcement while releasing the list of 19 communities and the different ways in which applicants from those communities will benefit.

The 19 disadvantaged communities are Detroit, Benton Harbor, East Lansing, Albion, Flint, Ecorse, Hamtramck, Highland Park, Inkster, Kalamazoo, Mt. Pleasant, Mt. Morris, Muskegon Heights, Muskegon, Niles, Pontiac, Saginaw, River Rouge and Ypsilanti.

During an exercise that lasted several months, the Marijuana Regulatory Authority put 150 stakeholders in workgroups and solicited input from them on how to select the disadvantaged communities that will benefit from the Social Equity Program, how qualifying individuals from those selected communities will be identified and what services or support should be provided to those selected individuals in the disproportionately affected communities identified. An online survey was also conducted seeking input on those same matters and 688 people responded to the survey.

From the results received, the MRA decided that disadvantaged communities would be selected based the number of marijuana-related convictions and the rate of poverty in those communities.

Taking the state’s marijuana conviction rate as a benchmark, counties that exceeded that state-level rate were identified for inclusion in the Social Equity Program.

From that group of counties, specific communities in which at least 30 percent of the population lived below the poverty level as defined by the federal government were selected.

MRA plans to start receiving applications from those intending to start marijuana businesses on Nov. 1 this year. Before that date, the authority will visit the 19 selected communities several times to educate the targeted population about the application and licensing process in relation to the Social Equity Program.

The representatives of MRA’s Social Equity Program will also help people from those communities to fill applications for participation in the Social Equity Program. These applications will then be scrutinized to confirm that those individuals qualify to benefit from the program.

The people who qualify stand to enjoy up to 60 percent reductions on the applicable fees for a marijuana business license.

For example, being a resident of one of the 19 listed communities for at least five years will earn the qualifying applicant a 25 percent waiver on the payable fees.

An additional 25 percent waiver will also be given to those who are the majority shareholders in the planned marijuana business which will be located within the disadvantaged community. The individual holding the majority ownership stake must also have a cannabis-related conviction in order to qualify for this additional 25 percent fee waiver.

A further 10 percent waiver will also be given to the Social Equity Program applicants who have also served as registered caregivers for at least two years in the period 2008-2017.

The members of the 19 communities will also get help in addressing all the issues related to running a marijuana business in the state. These include tax matters, employment law, workplace safety and health, environmental issues among others. Applicants will also be linked to other state departments and agencies whose services are pertinent to the marijuana industry.

The Social Equity Program appears to be a well thought-out plan that analysts believe will please cannabis industry players like Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) and MustGrow Biologics Corp. (CSE: MGRO) that insist action must be taken to correct the wrongs committed during the war on drugs.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company, this morning released an update summarizing the recent MjMicro Conference. CNW acted as the official newswire and media sponsor of the event which was held at the Westin Grand Central in New York City on June 25, 2019. Per the update, the investor conference was attended by exceptional presenting companies that were approved following a meticulous vetting process, ensuring an ideal environment for networking for all conference attendees. The news release also announced that the second annual MjMicro Conference is slated to take place on October 16 at the Sofitel Hotel in Beverly Hills. “The inaugural MjMicro Conference in New York City was a tremendous success with a quality lineup of presenting companies and a diverse crowd of attendees,” CNW Director of corporate sales Matt Ernst stated in the news release. “Networking opportunities were plentiful thanks to the intimate venue space, which featured presentation rooms in close proximity to gathering spots and well-organized one-on-one meeting rooms. We look forward to sponsoring future MjMicro events and to seeing this conference become a standard in the cannabis space.”

To view the full press release, visit http://cnw.fm/D7njB

About MjMicro

MjMicro is an invitational forum that unites publicly traded cannabis companies led by seasoned executives with next level, high net worth investors. C-level executives from presenting firms have the opportunity to meet one-on-one with next-level investors, with a focus on discussing structured investments and providing insight into growth plans. For more information, visit the company’s website at www.MJMicro.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The recent wave of adult-use marijuana legalization across the U.S. has the potential of generating $22 billion in annual sales, but not everyone is thrilled about this development. New research that will soon be published in the Marketing Science journal shows that the alcohol industry is likely to take a hit once marijuana is legalized.

The research was done by Pengyuan, an assistant professor at the Terry College of Business (University of Georgia). He worked with Guiyang Xiong from Syracuse University.

The duo analyzed online search data taken from one of the leading web portals based in the U.S. In total, they crunched the numbers on 120 million ad impressions and 28 million anonymous searches done using this portal. The data in question covered the period January 2014 to April 2017.

The research revealed that the number of online searches done for alcohol reduced by almost 11 percent while the searches for tobacco and its products saw an increase of 8 percent.

The tobacco and alcohol industries are worth a total of $300 billion in the U.S. alone. While these two industries have been vehemently opposed to the legalization of cannabis, this research shows that the tobacco industry would be well advised to revisit their opposition to legal marijuana since opposing the advance of cannabis isn’t in their best interest.

However, the alcohol industry is justified (from an existential point of view) to oppose the onward march of legal marijuana across the country since a law legalizing marijuana at the federal level would see a major decline in the sales of alcohol. The industry therefore has to think fast and come up with ways to retain their customers if they want to retain as much of their market share as possible.

Interestingly, while this research revealed that the legalization of adult-use marijuana in a state causes 17 percent more adults to conduct online searches on marijuana, the number of people who are less than 19 show a reduced interest in marijuana (or at least they perform fewer online searches on the substance).

This again serves to dispel another perception that the legalization of recreational cannabis causes a spike in the interest shown in the substance by minors. Policymakers may therefore need to revisit their positions if they based any decisions they made upon a presumption that there will be an uptick in the number of people who show interest in the drug yet they aren’t of age.

These findings seem to make sense because pollsters have pointed out severally that many adults would opt for recreational marijuana rather than alcohol since pot doesn’t come with hangovers, weight gain and the other effects of consuming alcohol on a regular basis.

It would be interesting to know what industry players like Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)  are planning to do in response to the likely spike in the opposition of the alcohol industry once the findings of this research are released and the fears of the alcohol industry are confirmed.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

If the current trend of cannabis sales during the Fourth of July holiday continue, marijuana could outsell wine as soon as July 4 next year, according to new data collected on different staples during Independence Day celebrations.

The week in which this year’s Independence Day fell saw a record $400 million worth of cannabis sold by dispensaries across the country. Statistics show that this figure is 60 percent above the national average of the marijuana sales made during any typical week of the year.

The data collected and analyzed by Akerna Corp shows that every single day leading to July 4 registered a spike in the volume of marijuana sales when compared to typical days across the country.

For example, on July 1, there was a 45 percent increase in the sales registered by marijuana dispensaries when compared to the available data on typical Mondays. While this jump is sizable, it was the least sales bump in the days leading to the national holiday.

On Wednesday (July 3), marijuana dispensaries registered sales which were more than twice what they usually sell on any average Wednesday. In fact, the increase was 112 percent when compared to sales on ordinary Wednesdays in the year.

Bumps were also noticed in the average amount that each person spent at a cannabis dispensary during the days leading up to the Fourth of July. Similar bumps were also noticed regarding the number of products bought per person on those days.

To put these marijuana sales in context, Green Entrepreneur compared the $400 million generated from marijuana sales to other staples sold on such days. Americans spent $1billion on beer and another billion on fireworks on Fourth of July last year. Wine generated total sales worth $568 million on the same day last year.

If these growth rates stay the same, it is highly likely that marijuana sales on Independence Day will exceed those of wine next year.

These figures and predictions seem all the more credible given the fact that the number of Americans who believe that marijuana should be legalized federally is at an all-time high. Additionally, more states are legalizing marijuana for medical and recreational purposes, with Illinois being the latest to enact an adult-use marijuana legalization law.

Industry watchers believe that this boom in cannabis sales will give industry players like Hemptown USA and Green Hygienics Holdings Inc. (OTCQB: GRYN) added impetus to take bolder steps towards consolidating their positions in the industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is supporting many of these companies that have cultivation licenses by providing cultivation and extraction equipment. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), one of the biggest companies in the sector, is increasing its growing capacity while helping educate about medicines. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) is leaning into new technology, with new facilities for R&D and processing. The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) (TGODF Profile) has tapped into the demand for organic produce and is now expanding into global CBD market. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) is developing powerful new medicines, in which hemp could help tackle previously uncurable illnesses.

To hear the CannabisNewsAudio version, visit http://cnw.fm/06dBg

To view the full editorial, visit http://cnw.fm/B5tv9

About Sugarmade Inc.

Sugarmade Inc. is a product and brand marketing company investing in products and brands with disruptive potential. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Mainstream retailers across the United States are embracing the growing popularity of the nonpsychoactive cannabinoid, cannabidiol (CBD), making room for CBD products on their prominent shelves.

With the rise of these cannabis beauty products, major stores from luxury retailers Barney’s and Neiman Marcus down to Walgreens, Rite Aid and now Kroger are stocking products from a range of CBD SKU producers, including Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) (GGBXF Profile), Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) (OGI Profile) and HEXO Corp. (TSX: HEXO) (NYSE American: HEXO).

To hear the CannabisNewsAudio version, visit http://cnw.fm/sC5as

To view the full editorial, visit http://cnw.fm/zL8pQ

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S., its CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space.

Savvy companies such as Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary Khrysos Industries Inc. just signed a five-year contract to purchase hemp plant biomass for extraction, end-to-end processing and production of hemp-derived products. Indiva Limited (TSX.V: NDVA) (OTCQX: NDVAF) has successfully received an amended license from Health Canada for three additional grow rooms and three additional processing rooms. Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT) recently announced that its wholly owned subsidiary received a notification letter from Health Canada indicating that all requested license amendments have been approved. Other cannabis companies are making strategic moves in the industry as well. CannaRoyalty Corporation (CSE: OH) (OTCQX: ORHOF) has obtained final approval to move forward with its plan of arrangement with Cresco Labs, which will result in the largest-ever public company acquisition in the U.S. cannabis sector. And KushCo Holdings Inc. (OTCQX: KSHB) has partnered with C.A. Fortune, a leading full-service national consumer products sales and marketing agency, with the intent to grant…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Pecho…what? If you are hearing about the Pechoti method for the first time, you aren’t alone, although this mode of administration of alternative remedies isn’t new. It entails putting drops of essential oils on the belly button as a way of treating different conditions, including PMS, nausea and pain. Now some people have been suggesting that one can ingest cannabis oil in this way. But is this even possible?

What the Pechoti Method Is

As mentioned earlier, the Pechoti method refers to an old Ayurveda treatment method in which essential oils are dropped onto the belly button to combat different conditions.

The Pechoti method derives its name from the Pechoti gland which is said to exist right behind the belly button. This gland remains in existence even if an infant’s umbilical cord is cut, and the gland remains throughout one’s life, according to the believers in this method of treatment.

The advocates of this method reason that once a human is formed in the womb, all the nutrition goes through the umbilical cord until the baby is born. They argue that if a baby could entirely depend on what is coming through the umbilical cord, why shouldn’t an adult continue using this vital part?

How It Works

Doctors who believe in this treatment method, like Dr. Lakisha Jenkins, say that approximately 72,000 veins pass through the umbilical cord and continue to all parts of the body. This means that any oil that is placed on the belly button is eventually absorbed and circulated throughout the body.

Dr. Jenkins adds that the gastrointestinal tract contains multiple cannabinoid receptors. The gut also plays a critical role in our immune system as well as the central nervous system. When cannabis oil is applied to the belly button, it navigates its way to the whole body through the veins that pass through the belly button.

Who Should Use this Method?

Proponents of the Pechoti method say that it works in the same way as suppositories since both are systemic (work on the whole body rather than the small part where they are applied). Since the cannabis oil administered in this way isn’t metabolized in the liver, a user cannot get high.

Consequently, kids and people who are so ill that they cannot smoke marijuana or ingest it orally can benefit from the Pechoti method.

People with endocrine system disorders, nervous system problems, gastrointestinal issues and those with neurological complaints are some of the people who can try using the Pechoti method to administer their cannabis oil treatment.

However, the effectiveness of the Pechoti method for using cannabis oil is subject to one condition; one must use organic oil from a trusted source so that the risk of impurities entering your bloodstream is avoided.

Analysts believe that the cannabis industry players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP), must be amazed at how creative people have become in coming up with different ways to ingest cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

On Monday, we reported that a key senate committee would soon schedule a hearing on marijuana banking. Now the Republican-controlled committee on Banking, Housing and Urban Affairs has revealed that it will hold this hearing on Tuesday next week (July 23).

This announcement comes as yet another indicator that marijuana reform is gaining momentum at the highest levels of decision making in the country. The legislation to be discussed is geared at finding a solution to the challenges that marijuana businesses have been having regarding access to banking services.

A similar law, which was passed by a Congressional committee, now has almost half of the members of Congress as co-sponsors after 206 representatives signed on. The Senate companion bill so far has 32 senators signed on from a total of 100 senators in that chamber.

The senate hearing slated for Tuesday is titled “Challenges for Cannabis and Banking: Outside Perspectives.” Representatives of CUNA (Credit Unions National Association), Smart Approaches to Marijuana (a prohibitionist advocacy group) and Citywide Banks will testify during this hearing.

Jim Nussle, the CEO and president of CUNA remarked that his organization was willing and happy to work with senate leaders to find a solution to marijuana banking which is a public safety issue.

John Lord, the CEO of LivWell Enlightened Health (a marijuana retail chain) is also lined up to testify before the senate committee, as will Cannabis Trade Federation’s Neal Levine (who also testified before a sub-committee of Congress on how prohibition can be ended).

Sen. Cory Gardner (R-CO), the main GOP cosponsor of the Senate cannabis banking bill has also been booked to appear before the committee during this hearing.

Support for marijuana banking has been growing steadily with pressure being mounted for action on this matter by the highest financial sector regulators in 25 states, a huge majority of state attorneys general, 20 state governors from both sides of the political divide, banking associations from 50 states across the country and the National Association of State Treasurers. All these groups want the STATES Banking Act to be passed by Congress.

While Chairman Crapo is personally opposed to marijuana, his scheduling of the senate committee’s hearing on this matter shows that he recognizes that matters of cannabis banking present serious public safety concerns that have to be addressed soon rather than later.

Consensus is also growing on the need to make broader reforms to marijuana policy beyond access to banking services. The clearest example of this was the Congressional subcommittee hearing last week at which all parties agreed on the need for reform although there were some disagreements on how that reform can be realized.

Industry watchers believe that the entire marijuana industry, including Geyser Brands Inc. (TSX.V: GYSR) and Earth Science Tech Inc. (OTCQB: ETST), is now encouraged to believe that federal marijuana reform may happen soon.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

If you’re known by the company you keep, then the NCIA is moving with the right crowd. Mike Lee, executive VP & CFO of Canopy Growth Corporation (NYSE: CGC), will be a keynote speaker at the organization’s 6th Annual Cannabis Business Summit & Expo, to be held July 22-24 at the San Jose McEnery Convention Center in San Jose, California. In the cannabis world, they don’t come bigger or better than Canopy Growth. The Ontario-based CGC was the first cannabis company to be listed on the New York Stock Exchange and the industry’s first ‘unicorn’. It is now valued at over $13 billion.

NCIA’s Cannabis Business Summit & Expo is about more than name dropping, though. A turnout of over 7,500 is expected, as executives, investors and other actors in…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

On Monday, the Department of Health in New Jersey announced that interested parties could start submitting their applications to grow and sell marijuana. Both nonprofit and for-profit entities are eligible to apply during this round of licensing.

Those planning to be growers or sellers of medical marijuana have until August 21 to submit their applications. New Jersey plans to license five additional cultivation facilities as well as 15 medical marijuana dispensaries. 4 licenses will also be granted to “verticals.” These are entities which are vertically integrated (they can cultivate, process and sell marijuana).

Entities that apply for the licenses will pay an application fee of $20,000 and those whose applications aren’t successful will get back $18,000 of that application fee.

All the people involved in the companies that apply have been notified that they will be subjected to a criminal background check. These people include directors, owners, board members and employees.

The interested companies are also expected to provide proof that the local authorities in the area where they wish to operate have given them approval to operate a marijuana business in that area.

Another requirement is that the companies must submit their security plans as well as an environment impact statement as they send in their applications.

All the companies that apply are expected to show that they have sufficient experience in the particular aspect of the industry for which they would like to be licensed. For example, aspiring growers must show they have experience cultivating medical marijuana. Quality assurance and quality control are important, so applicants are also required to submit their plans for these aspects of their operations.

While the state hasn’t imposed any minimum level of capitalization that aspiring industry participants should have, the applicants are nonetheless expected to provide proof that they have sufficient funding for the operations they wish to undertake. Funds should be available for the activities shown in their plans.

The state has also organized a pre-application webinar for all those interested on August 2. The Department of Health has revealed that people can submit the questions that they would like the department to address during that webinar. While it may not be practically possible to respond to each of the questions submitted, the state will address the issues that cut across the queries sent in.

This medical marijuana program expansion comes at a time when plans to legalize adult-use pot failed after advocates failed to secure ample support in the state senate and a vote on the matter was called off at the last minute. Analysts expect that the cannabis industry, including entities like Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and ChineseInvestors.com Inc. (OTCQB: CIIX), will take comfort in the fact that with the expansion of the medical cannabis program, patients will get solutions to many of the issues that they have been facing, such as lack of variety in the products available.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

New research shows that as marijuana started being legalized for recreational purposes in different states across the U.S., the reported cases of illicit grow sites within protected lands started falling.

The research findings, released in Ecological Economics, specifically point out that illegal grows on national forests saw a major decline in the Pacific Northwest after cannabis legalization started.

USDA’s Forest Service analyzed the available data on the illegal marijuana grow sites discovered and reported between 2004 and 2016. This data was in regard to 111 national forests. The researchers considered several factors, such as the retail price of pot, state laws, risks of being discovered running an illegal grow site, and many others.

The researchers then used that data to create six different simulations of what would happen to the number of illegal grows if marijuana policies changed.

For example, one simulation seeks to see how the number of these illegal grows would change if all the state laws legalizing both medical and recreational cannabis were revoked. Another simulation explores what would happen assuming that all the taxes on the legal marijuana on the market were waived/eliminated.

The researchers found that policies legalizing some form of marijuana are linked to a reduction in the number of reported cases of illegal grow sites within national forests.

The predictive models of the research also show that if the existing medical and recreational marijuana laws in different states were to be revoked, then the rate at which illegal grow sites would be discovered is likely to grow by double digit percentages while expanding the number of states with laws legalizing marijuana would reduce such grows by at least a fifth, as per the available 2017 data.

For example, if all the 23 states that had enacted medical cannabis laws by 2016 enacted recreational marijuana legalization laws as well, then the illegal grows within those areas would reduce by at least 35 percent and as high as 51 percent.

While the researchers found that marijuana decriminalization didn’t have any effect on illegal grows, they discovered that imposing harsher penalties on those convicted on charges related to illegal marijuana cultivation activities had an effect of reducing the number of illegal grows. Increasing law enforcement personnel in the national forests only had a negligible effect on the stats, according to the research.

The study concludes that of the two ways (legalization and increased enforcement) to reduce illegal grows in forests, legalization offers a more cost-effective way to preserve the forests from the attendant problems, such as the use of strong rodenticides, which come with the illegal grow sites.

Analysts think industry players like Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) and Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) aren’t surprised by the findings of this research since the cannabis industry has always asserted that legalization can stamp out the black market and its risks.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The must-attend event for cannabis industry professionals and enthusiasts – The Cannabis Consumer & Business Expo Toronto 2019 – is slated for late November. The expo is scheduled to take place at the Queen Elizabeth Building located at Exhibition Place in the heart of Toronto, Canada from November 22 to 24, 2019. The event, billed as one of North America’s fastest growing cannabis expos, is expected to draw over 20,000 attendees, 200-plus cannabis-related exhibitors, and several dozen industry-specific experts. Already headlining the 3-day immersive event are leading cannabis professionals from Starbuds and Hydroponics. Attendees will enjoy B2B and B2C seminars, workshops, exhibitor-sponsored events, tremendous networking opportunities, and exposure to expert insight surrounding the rapidly evolving cannabis space. The expo will highlight key topics including cannabis industry challenges, opportunities impacting its future, and lessons learned from innovators of the quickly growing sector.

To view the full press release, visit http://cnw.fm/7fgNR

About Cannabis Consumer & Business Expo

Cannabis Consumer and Business Expo is a place where businesses meet and establish long term relationships, networking opportunities and gaining further insights into new products and services available. Consumers can learn about different options and health benefits of cannabis products and services on the market today. The Cannabis Consumer & Business Expo Toronto 2019, scheduled Nov. 22nd-24th, 2019, at the Queen Elizabeth Building located at Exhibition Place in the heart of Toronto, Canada, will feature business seminars, workshops, panel discussions, exhibitors and multiple opportunities to network with like-minded business owners and entrepreneurs. To learn more about The Cannabis Consumer and Business Expo 2019 in Toronto, visit www.CannabisTradeExpo.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Mainstream retailers across the United States are embracing the growing popularity of the nonpsychoactive cannabinoid, cannabidiol (CBD), making room for CBD products on their prominent shelves.

With the rise of these cannabis beauty products, major stores from luxury retailers Barney’s and Neiman Marcus down to Walgreens, Rite Aid and now Kroger are stocking products from a range of CBD SKU producers, including Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) (GGBXF Profile), Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) (OGI Profile) and..

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is supporting many of these companies that have cultivation licenses by providing cultivation and extraction equipment. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), one of the biggest companies in the sector, is increasing its growing capacity while helping educate about medicines. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) is leaning into new technology, with new facilities for R&D and processing. The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) (TGODF Profile) has tapped into the demand for organic produce and is now expanding into global CBD market. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) is developing powerful new medicines, in which hemp could help tackle…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

The Senate Banking Committee could schedule hearings on bipartisan legislation on cannabis banking in as little as two weeks. This revelation was made by the chairman of that committee, Mike Crapo (R-ID) as he talked to American Banker.

Crapo said that he was looking into the prospect of scheduling a hearing on the matter and added that the hearings will be “relatively soon.”

This statement marks a huge change of heart for the senator from Idaho who is on record saying (in April) that he wouldn’t commit his committee to holding sessions on marijuana banking as long as marijuana is still illegal at the federal level.

Banking industry insiders believe that the committee is likely to have two hearings in the week starting July 22. One hearing will be centered on hearing from the regulators of the banking sector while the second hearing will listen to the other stakeholders on this matter.

A similar bill was passed by the Congressional Banking Services Committee in March and similar language to the contents of the STATES Act was included in the appropriations bill.

While pro-cannabis advocates have been hoping that the STATES Act is put on the schedule for a vote by the entire House before the legislative chamber goes for recess in August, this hasn’t happened as yet. It now seems that a vote on the bill may have to wait until the fall.

Concerns have also been voiced about how the STATES Act would be received once it gets to a Senate that is dominated by Republicans.

Rep. Ed Perlmutter (D-CO), the chief sponsor of the House version of the bill, revealed that lawmakers are currently exploring other ways to generate Republican support for the bill. One of the avenues being explored is including language to the effect that regulators will not prevent payday lenders and gun manufacturers from accessing banking services.

Another avenue that could be used is the inclusion of language that protects the hemp industry so that Republicans don’t look at that the bill as one on just marijuana.

A senate hearing on marijuana business banking would mark another milestone for those who want to see marijuana policy reform. While the STATES Act will not alter the status of marijuana federally, it is a step in the right direction since many advocates see the incremental approach to legalization as a more realistic option when compared to the chances of a standalone bill on legalization passing in both chambers.

Industry watchers believe that the entire cannabis industry, including Cannabis Strategic Ventures Inc. (OTCQB: NUGS) and Youngevity International Inc. (NASDAQ: YGYI), will be waiting with bated breath to hear what comes out from the Senate committee hearings.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Last week, the Crime, Terrorism and Homeland Security sub-committee of the powerful House Judiciary Committee held a landmark session in which they listened to testimony from a variety of experts on how marijuana prohibition could be brought to an end federally.

This hearing was largely focused on evidence, unlike previous Congressional discussions on the matter that largely seemed to be driven by scaremongering. However, there were some disagreements regarding the strategy that should be used to legislate marijuana policy reforms.

For example, Rep. Tom McClintock (R-CA) argued that the Democrats were wrongly framing the issue along racial lines and this would divide the country. The Chairperson of the House Judiciary Committee, Jerrod Nadler, responded by saying that marijuana laws had been designed and implemented in a racially disparate manner, so the solution should also emerge after considering the racial factors involved.

Nadler added that in his own opinion, it is ill-advised to use marijuana, but that doesn’t mean the drug should be criminalized. Instead, adults should be left to make informed decisions on the substance as is the case with other substances like alcohol and cigarettes.

While testifying before the subcommittee, Malik Burnett, a physician at the Johns Hopkins Bloomberg School of Public Health said that it was wrong to have two widely different situations on the subject of marijuana. He explained that the U.S. can be divided into two, with one half made up of whites who are minting billions from state-legal marijuana while the other half of the U.S. made up of poor people, especially blacks, are arrested in their thousands for the same marijuana that whites are getting rich from.

Marilyn Mosby, the State Attorney for Baltimore also told the subcommittee that the current lopsided enforcement of marijuana laws not only worsens the existing inequalities in the U.S. justice system but also alienates the community from law enforcement agencies. No public safety benefit accrues from the enforcement of marijuana prohibition, she added. She concluded by saying that full legalization is the way to go since decriminalization of marijuana isn’t enough. Mosby’s office is noted for announcing earlier this year that they would no longer prosecute marijuana possession cases.

Davis Nathan, the president of Doctors for Cannabis Regulation (a pro-marijuana legalization group of physicians) testified that the prohibition of marijuana has done more harm than any good that was anticipated. He also said that the drug should never have been criminalized since it is less harmful than tobacco and alcohol.

There was a heated discussion regarding the way in which cannabis reform should be made to happen after Neal Levine, the CEO of Cannabis Trade Federation) suggested that the process should be incremental, starting with the passing of the STATES Act currently before lawmakers.

For example, Rep. Steve Cohen (D-TN) wondered why full legalization shouldn’t be done in one fell swoop since prohibition had lingered for far too long. Other lawmakers disagreed and preferred the cautious approach of incremental policy adjustments in order to avoid passing bills that ultimately fail once they reach the Republican-controlled Senate.

Industry pundits strongly believe that the cannabis industry, including players like Willow Biosciences Inc. (CSE: WLLW) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), is hoping that concrete action follows this hearing on the modalities of ending marijuana prohibition.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A marijuana education and advocacy group in Arkansas has announced that it plans to file two petitions with the state government so that recreational marijuana can be legalized through a ballot measure. The second petition covers the expungement of marijuana-related convictions.

Drug Policy Education Group (DPEG), the nonprofit planning the petitions, says that they had initially wanted to have both issues (legalization and expungement) in the same initiative. However, their legal advisors recommended that they submit separate petitions since it would be hard for the Attorney General to approve a petition which has a constitutional amendment within another proposed amendment.

Melissa Fults, the Executive Director of DPEG, revealed that they had been planning the petitions for more than a year but they decided to move quickly since the lawmakers seem to be moving towards making it harder for voters to effect changes to the state constitution.

Fults revealed that there was consensus among pro-medical marijuana advocates that the Medical Marijuana Commission (MMC) and the State General Assembly had deliberately delayed the launch of the medical cannabis program after voters approved a constitutional amendment in 2016. Sales started 2.5 years after the constitutional amendment, and sales totaling $2 million had so far been registered.

Fults and other advocates have been trying to see more reforms made to the existing cannabis laws. For example, they tried to expand the list of medical marijuana qualifying conditions to three times its current size but the bill failed to make it beyond committee level during the legislative session that has just ended.

The first petition, named Arkansas Adult Use Cannabis Amendment (AAUCA) seeks to give the state’s finance department, through its Alcohol and Beverage Control Division, permission to draft regulations for the recreational marijuana program (cultivation, manufacturing, testing and sales). Under the proposal, adults who are at least 21 years old will be allowed to purchase recreational marijuana in addition to having a maximum of six seedlings and six mature plants for their own use.

The second ballot petition, named the Arkansas Marijuana Expungement Amendment (AMEA), seeks to allow people who were convicted for possessing up to 16 ounces of cannabis to petition a court (which will be set up for this purpose) to be released from prison, have the conviction expunged or request for the restoration of their rights.

Under Arkansas law, any proposed petition for the passing of a new law requires signatures of at least 8 percent of the voters who participated in the most recent elections. A petition for a constitutional amendment requires 10 percent voter support to be approved for inclusion on the ballot.

The nonprofit and its supporters therefore have their work cut out if their petition is to see the light of day. Pundits think that the entire cannabis industry, including participants like VPR Brands LP (OTC: VPRB) and VIVO Cannabis, Inc. (TSX.V: VIVO) (OTCQX: VVCIF), will be rooting for the success of the initiatives since adult Arkansans will be able to enjoy the numerous benefits of the adult-use marijuana industry, such as employment.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The global legal cannabis market size is predicted to reach $66.3 billion by the end of 2025. This market is expected to grow at a compounded annual growth rate (CAGR) of 23.9 percent within the years covered in the forecast. The increasing legalization of marijuana and the demand for medicinal marijuana is expected to be the key driver of this market growth.

In the coming years, the growing demand for cannabis products in the treatment of various health conditions, such as Alzheimer’s, cancer, Parkinson’s, arthritis, and several neurological conditions is expected to boost the demand for marijuana as a pharmaceutical product.

Additionally, many countries and jurisdictions have legalized marijuana either for recreational or medicinal purposes. This has had a major adverse effect on the black market of marijuana in those areas, and this is a plus for the legal industry that will see the market expand at the predicted pace. The desire for governments to earn from the legal industry is another factor that will contribute to further legalization and expansion of the marijuana market.

Regionally, the demand for marijuana products is likely to be largely driven by the huge market in the U.S. and Canada, especially for medical marijuana. In contrast, the stringent regulations and rules imposed on the cultivation and sale of medical marijuana in Europe may dampen the growth of the industry on the European continent even if markets like Germany offer great promise.

At the moment, Israel is playing a pivotal role of sharing its technological prowess and cannabis knowledge with other parts of the world. As these markets, such as Thailand the U.K, open and grow, the global market will benefit from these potentially major players in the industry.

The report also points out that in 2018, the cannabis market in the U.S. was valued at $11.9bn and it is expected to grow at a compounded annual growth rate of 24.1 percent for the duration of the forecast in the report till the end of 2025.

Cannabis buds or dried flower took the lion’s share of the global marijuana market in 2018 because it accounted for more than half of all the sales recorded in the industry. This segment is expected to grow at a CAGR of 20.6 percent during the forecast period.

Analysts strongly feel that this bullish outlook for the global marijuana industry will spur industry players like TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) to ramp up their own growth plans in order to cash in on the global growth of the industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

With demand outstripping supply, successful cannabis companies are following smart core strategies and reporting strong revenues.

Golden Developing Solutions Inc. (OTC: DVLP) (DVLP Profile) has used a mix of acquisitions, diverse brands and products, and increased production footprint to meet customer demand and report significant revenue increases, including its strongest second-quarter numbers ever. Industry giant Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has followed a similar path, though some change may follow the recent departure of its co-CEO. Tilray Inc. (NASDAQ: TLRY) has invested heavily in increasing production while reaching into new markets such as the United Kingdom. Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) and Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) have both shown the potential for growing multistate businesses in the United States, despite the challenges created by federal legislation.

To view the full editorial, visit http://cnw.fm/q2cYz

To hear the CannabisNewsAudio version, visit http://cnw.fm/Z5lKo

About Golden Developing Solutions Inc.

Golden Developing Solutions is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. The company is also developing a high-capacity, high-quality CBD extraction and production facility. In addition, through the website of its joint venture partner, Pura Vida Vitamins, as well as through wholesale and distribution channels, the company offers a broad range of high-quality, price-competitive products, including traditional vitamins; supplements; and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle. For more information, visit the company’s websites at www.PuraVidaVitamins.com and www.WheresWeed.com

NOTE TO INVESTORS: The latest news and updates relating to DVLP are available in the company’s newsroom at http://cnw.fm/DVLP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The Marijuana Justice Coalition, an entity that brings together different groups that want to see justice in all matters connected to marijuana, have released a statement in which they outline the principles that the federal government and Congress should bear in mind as they consider bringing an end to the prohibition of marijuana nationwide.

The entities which signed this statement include Human Rights Watch, Center for Law and Social Policy, Immigration Legal Resource Center, Students for Sensible Drug Policy, Center for American Progress, Drug Policy Alliance, and NORML, among others.

The group starts by remarking that marijuana prohibition has devastated people’s lives for decades, and that 600,000 people are arrested annually for marijuana-related offenses. However, people of color are disproportionately affected since their chance of being arrested quadruples the chance of a white person being arrested for marijuana possession even if the rates of using the substance don’t vary across the races.

The coalition also points out that minor marijuana possession was the fourth most cited cause for non-citizens being deported from the U.S. The coalition was disturbed that these arrests and deportations continue even when polls show that 68 percent of American voters favor an end to prohibition while 73 percent say that marijuana convictions should be sealed automatically.

The Marijuana Justice Coalition suggests seven principles that Congress should think about and include in any legislation that will bring cannabis prohibition to an end.

For example, they say that marijuana should be descheduled since retaining it in the Controlled Substances Act preserves the criminalization of marijuana and provides a basis for the continued enforcement of prohibitionist laws.

Any law passed should also include provisions that get rid of barriers to public benefits, such as housing, nutritional assistance and other benefits that people are otherwise entitled to or eligible for.

Additionally, the coalition wants to see protections from immigration action against non-citizens who use or participate in the marijuana industry once it is legalized federally. This is aimed at ending the arrests and deportations, as well the denial of entry into the U.S.

Another principle listed by the Marijuana Justice Coalition has language to the effect that a portion of the revenue generated by the federal government from the marijuana industry should be allocated to entities or units of local governments that will reinvest that money in communities or individuals most impacted by the prohibitionist laws, especially for removing the collateral harms (lack of access to education or housing loans, for example) of the war on drugs.

This statement comes at a time when a Congressional sub-committee is receiving testimony from different experts who are expected to shed light on how prohibition can be ended. Analysts opine that the entire cannabis industry, including players like The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) could be very pleased that this influential group has come out so strongly on the issues that will bring justice regarding all things marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Last week, Gov. Phil Murphy signed a bill that will expand the medical marijuana program of the state. One of the notable changes in the bill is that patients who could only possess a medical cannabis supply that can last 90 days can now legally possess a year’s worth of medical marijuana supplies.

This change has been applauded by pro-marijuana advocates because it will reduce the inconveniences and costs associated with making frequent trips to a dispensary, especially for patients and caregivers will don’t stay near a provisioning center and those who have mobility challenges.

The number of medical cannabis producers has also been increased, This was in response to complaints about high product prices and a limited variety of medical marijuana products in dispensaries. It is hoped that the introduction of additional producers will make prices more competitive and it will also drive innovation so that patients have more variety to select from.

The new law also increases the number of medical conditions for which patients can qualify for medical marijuana permits, a move that analysts believe was welcome news to the entire industry including players like Sugarmade Inc. (OTCQB: SGMD) and Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) since a potentially bigger market was created for the medical marijuana products of the cannabis companies within the state.  In the past, only sufferers of debilitating conditions could get a medical marijuana license. With the signing of the new law, other conditions, such as post-traumatic stress disorder, chronic pain, cancer, opioid use disorder, glaucoma and epilepsy can qualify a patient to use medical marijuana.

Home delivery of medical marijuana will become a reality once this law takes effect. This is seen as making medical marijuana more accessible for people in areas that don’t have a dispensary. More jobs will also be created for those who participate in the home delivery service.

Since coming into office, Gov. Murphy has so far expanded the medical marijuana program twice. Under his administration, the number of patients has grown to 49,000 from just 15,000 during the time of his predecessor (Gov. Chris Christie). Now that more qualifying conditions have been added, the number of patients will increase even further.

While pro-marijuana advocates are happy that the medical marijuana program has been expanded, this law comes at a time when people are still disappointed that recreational marijuana wasn’t legalized as had widely been expected during the legislative session that ended recently.

The lack of sufficient support for the legalization bill in the state senate made legislative leaders to call off a vote on the bill, and frantic negotiations last month couldn’t secure the needed votes. It now appears that the issue may go to voters during the elections next year or the next midterms.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

An inventor in Michigan has invented a pill that is aptly called “Parachute” aimed at helping anyone who realizes that they are too high on marijuana to come down from that high.

Steve Goldner, the founder of Pure Green, says that it can be dreadful when one consumes cannabis edibles and realizes when it is too late that what they have consumed has made them higher than they had intended to be. This is particularly possible since people who ingest marijuana orally take longer to notice the effects unlike those who use other modes of administration, such as smoking or using a cannabis suppository. This is because the process of digestion takes long, so the ingredients in cannabis take longer to enter the bloodstream.

Goldner therefore invented the Parachute pill in order to give users a way to quickly reverse the effects of marijuana.

This mint-flavored pill has cannabidiol (CBD) as its primary ingredient. One simply places this pill under the tongue and they will notice their high subsiding within five minutes. Goldner boasts that this sublingual administration is more user-friendly than rolling a joint, chewing a pill or administering an injection.

Steve Goldner explains that he chose this sublingual way of providing relief to those who are too high because of its quick results as well as a consideration that someone who is very high may not find it easy to execute several steps to reverse their cannabis intoxication.

This isn’t the first medical marijuana product that Goldner has brought to market. He rose to fame in the 1970s when he made liquid methadone to deal with opioid addiction. His company also makes Pure Calm, a remedy for anxiety, as well as Pure Relief, which is formulated to combat pain. All these remedies are made from hemp-derived CBD.

Goldner’s company was among the first companies to get pre-approval from the Medical Marihuana Licensing Board of Michigan in April 2018.

Goldner’s invention of the Parachute pill shows how different entrepreneurs are stepping up to provide answers to the different challenges faced by both medical and recreational users of marijuana. We have seen inhalers, tampons and other products being tested to administer marijuana in more ways so that people can have effective alternatives to smoking cannabis. As the industry matures, analysts expect players like SinglePoint Inc. (OTCQB: SING) and Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FRA: O3X4) to tweak their offerings in order to embrace the expanded product list in the cannabis space.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Marijuana triggers a rewarding high in some people while the substance brings serious psychiatric effects when other people consume it. This contradiction in the way cannabis affects its consumers has baffled the scientific community and researchers from the University of Western Ontario in Canada appear to have uncovered the reason for this difference.

The scientists suggest that how one is affected by marijuana may depend on which part of the brain is acted upon by the substance. For some people, the highly rewarding “high” they experience after consuming marijuana can increase their likelihood of becoming addicted to cannabis. For others, the consumption of cannabis can result in paranoia, schizophrenia and other cognitive problems.

The study done on rodents reveals the different regions of the brain which account for these different effects of taking marijuana.

The scientists discovered that the THC in marijuana triggers highly rewarding effects when it reaches the front part of the nucleus accumbens, a region found at the front of the brain. Furthermore, the research showed that once THC reaches this part of the brain, it magnifies the reward-related activity of the brain neurons in the area thereby amplifying the addictive attributes of opioids like morphine.

In contrast, if THC gets to the posterior of the region of the brain referred to earlier (the nucleus accumbens), highly adverse effects result. These effects are typically similar to what is observed in people who have schizophrenia-like behavioral, cognitive and neural activity.

Christopher Norris, PhD, one of the lead authors of the study, explains that the findings above are very important because they provide valuable insights to explain why the experience of some people is positive when they use marijuana while others have a negative experience after using the same strain or amount of marijuana in the same consumption method.

The scientists go on to suggest that since the reward or aversion comes from different parts of the brain, the individuals who experience one of these two distinct effects seem to be genetically predisposed to have different regions of their nucleus accumbens affected by the THC in marijuana. If the sensitivity of the different parts of the nucleus accumbens is determined by genetics, then marijuana users can forestall future issues by refraining or reducing their use of the substance if they notice that they experience adverse effects each time they use cannabis.

These findings have analysts wondering whether industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) may consider developing methods to help people know whether they are likely to experience positive or adverse effects after using cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: With demand outstripping supply, successful cannabis companies are following smart core strategies and reporting strong revenues.

Golden Developing Solutions Inc. (OTC: DVLP) (DVLP Profile) has used a mix of acquisitions, diverse brands and products, and increased production footprint to meet customer demand and report significant revenue increases, including its strongest second-quarter numbers ever. Industry giant Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has followed a similar path, though some change may follow the recent departure of its co-CEO. Tilray Inc. (NASDAQ: TLRY) has invested heavily in increasing production while reaching into new markets such as the United Kingdom. Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) and Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) have both shown the potential for growing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

A newly published research paper is suggesting that while the overall number of young people who use marijuana has increased over the years, there appears to be a reduction in teen marijuana use in states where recreational cannabis has been legalized.

The legalization of recreational cannabis has been linked to an 8 percent drop in the number of high school teens who confessed that they had used marijuana in the past 30 days. There was also a 9 percent drop in high schoolers who reported that they had used cannabis a minimum of 10 times in the past 30 days.

Mark Anderson, the lead author of the study which was published on Monday this week, said that it was important for people reading the research findings to note that the researchers didn’t find any link between the prevalence of teen marijuana use and the passing of medical cannabis laws in different states.

The researchers also stressed that the study doesn’t suggest that when recreational marijuana laws are passed, then teen cannabis use drops. The study only points to an association, not causation.

The findings of the study were arrived at after analyzing the annual Youth Risk Behavior Surveys done by the U.S. CDC. The researchers specifically looked at the data collected between 1993 and 2017. This data included information on 1.4 million high schoolers.

The researchers zeroed in on the responses about marijuana use before recreational cannabis laws were passed and after legalization. The same was done for areas where medical marijuana laws were enacted.

The researchers believe that their findings are the most reliable on the matter, but they also added that many states didn’t have recent self-reported data on teen marijuana use since legalization laws had only started being implemented recently. They therefore vowed to update their statistics after a few more years to reflect the data sets on the states where recreational marijuana has recently been legalized.

However, this study seems to contradict what other studies have found. For example, the Criminal Justice Department in Colorado found that there was no change in teen marijuana use from the time recreational marijuana was legalized five years ago.

Commenting on this recent study, scientists have wondered why that drop in high schoolers using marijuana has been observed. Some suggested that when adult-use marijuana is legalized, it becomes harder to get cannabis off the streets, and this could limit teen access to the substance. It would be interesting to hear what marijuana companies like Net Element Inc. (NASDAQ: NETE) and Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) have to say about this potential explanation for the drop in teen marijuana use.

More research needs to be done to establish what exactly is causing the drop in teen marijuana use in places where recreational marijuana is legal.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The House Rules Committee of Congress is going to consider an amendment this week that seeks to stop the Department of Veterans Affairs (VA) from denying the home loan requests of veterans who derive all or part of their income from work in state-legal marijuana industries.

Rep. Katherine Clark (D-MA) filed the measure that, if passed, will be attached to the National Defense Authorization Act.

Previously, it wasn’t known to the public and lawmakers that the VA had a policy of denying any home loan application of a veteran who worked in a marijuana company in a state where the industry is legal. However, one constituent of the mover of this amendment drew the attention of the lawmaker to this issue early this year and Clark immediately started working to correct this practice.

In May, Rep. Clark spearheaded a move to get lawmakers to sign a letter addressed to the VA on this unfair policy. In their letter, they noted that a significant number of veterans work in the marijuana industry and more will join them as more states legalize the industry.

The bipartisan group of legislators urged the VA to acknowledge and clarify that veterans will not be denied their benefits just because of the industry in which they work.

At about the same time, the House Appropriations Committee wrote a report highlighting the lack of clarity on the rules of the VA on home loans for veterans who work in the state-legal cannabis industry. The panel went ahead to impose a 180-day deadline within which the department should clarify what its official position on this issue is.

Clark’s amendment has language to the effect that the VA will not use a veteran’s employment in a state-legal cannabis business as a basis to determine the suitability of that person for a housing loan.

Last month, another Congressional committee approved another amendment to the spending bill of the Department of Defense. That amendment permitted the reenlistment of members even if they had used or been convicted of misdemeanor marijuana offenses while off-duty.

However, the VA has a history of pushing against any pro-marijuana amendments that come up for discussion, and the latest amendment filed by Rep. Clark is likely to get the same treatment. It would be enlightening to know what the different industry players like MustGrow Biologics Corp. and Marijuana Company of America Inc. (OTCQB: MCOA) would suggest as a way to get around this brick wall of VA resistance to marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The cannabis industry is not for the faint of heart. Propelled by tailwinds of liberalization but facing a headwind from the feds, today’s cannabis enterprises can find themselves unsure of which course to chart. The National Cannabis Industry Association (NCIA) has their backs, however. At its 6th Annual Cannabis Business Summit & Expo, to be held July 22-24 at the San Jose McEnery Convention Center in San Jose, California, workshops on regulatory issues will provide informative counsel on compliance.

The schedule for the event includes a pre-conference workshop focused on ‘Best Practices for Starting an Indoor Grow Facility’, which will be complemented with off-site tours to gain a hands-on look at how it’s done. With its return to San Jose, Cannabis Business Summit & Expo is celebrating six years of cultivating the…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Contrary to the common perception that most people buy marijuana in order to get stoned, a new study done by the University of Miami and the Albert Einstein College of Medicine has found that the majority of those who buy marijuana in Colorado use the substance as a sleep aid. These findings are significant because recreational marijuana has been legal in the state for about 5 years now.

In the survey, 1,000 customers of two recreational marijuana stores in Colorado were asked a variety of questions about their motivation for using cannabis. 74 percent of the respondents revealed that they buy marijuana as a sleep aid while 65 percent confessed that they buy marijuana to combat pain.

About 80 percent of the survey participants who said they use marijuana for pain relief admitted that the substance was very helpful in that regard, and 88 percent of these people who had ever used opioids reported that because of using cannabis, their use of prescription opioids had reduced.

It isn’t altogether surprising that people are using cannabis to get some sleep. For long, marijuana has been known to have soporific (inducing sleep) effects and some research even suggests that CBD (cannabidiol) is responsible for expediting sleep and enhancing the overall quality of sleep that one has.

Additionally, while limited research is still available on the pain-relief effects of cannabis, some small studies indicate that marijuana may be a viable alternative to the traditional pain medication available on the market. Researchers think this is a strong possibility since the nerves which detect pain also have a large number of cannabinoid receptors.

The researchers who surveyed the cannabis buyers in Colorado wrote that if cannabis is legalized federally, there is a possibility that people’s dependence on strong prescription pain medications which have serious side effects could be reduced.

It has also been suggested that marijuana could be a good alternative if it is used as a harm reduction agent for people who are addicted to opioids.

The findings of this Colorado study are in line with another 2014 study whose findings appeared in JAMA showing that there was a reduction in the level of opioid use after marijuana was legalized.

While more research still needs to be done, industry experts think that the findings of the latest research in Colorado aren’t anything new to companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Hemptown USA since the cannabis industry has been talking about the different benefits of cannabis to different groups of people.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

More than half a year after Michigan voters approved a ballot measure to legalize recreational marijuana, the authorities have released emergency rules which will shape the recreational industry in the state. Here are some of key takeaways from those rules.

Local Authorities Have Until Nov. 1 to Opt Out of Hosting Cannabis Businesses

State authorities will start accepting recreational marijuana business license applications on Nov. 1 this year. Until that date, local authorities (townships and cities) can make up their minds whether they will or will not allow marijuana businesses to operate within their jurisdictions. Currently, 600 communities have opted out, but many of those were waiting to review the rules released by the state government before making a final decision on the matter.

Social Use is in the Offing

The state plans to issue special licenses to establishments that wish to have the social consumption of pot on their premises. However, those social consumption lounges will not be allowed to sell food or alcohol. If organizers of festivals and special events apply for a permit, marijuana consumption will also be allowed at such gatherings. Industry analysts wonder what industry players like Green Hygienics Holdings Inc. (OTCQB: GRYN) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) would make of this provision given the fact that marijuana lounges won’t be allowed to sell food or alcohol, but cannabis can be availed at festivals (where food and alcohol are also available).

Starting a Recreational Cannabis Business Will Be Easier Than Starting a Medical Cannabis Business

It will be easier for those interested in starting recreational pot business when compared to the requirements for starting a medical cannabis company. For example, those opening recreational cannabis businesses will not be required to prove that they have funds while those who start medical cannabis companies have to prove that they have between $200,000 and $500,000 in cash and assets before obtaining a license. It is also more affordable to get a license to grow recreational marijuana than get one for growing medical marijuana.

One Store Can Sell Both Medical and Recreational Marijuana

The emergency rules also have clauses allowing medical cannabis provisioning centers to sell recreational marijuana as well if the two types of products are stored or displayed in different sections of the store. The entrance and points-of-sale systems can be the same for both types of buyers.

Medical Cannabis Plants May Be Transferred to Recreational Marijuana Grow Facilities

In the beginning, plants originally cultivated for the medical marijuana market may be transferred to a facility cultivating weed for the recreational market. This provision has been created in order to minimize supply kinks as recreational marijuana sales are launched.

A Plan for Social Equity in the Industry is Being Drafted

The state authorities have also indicated they will release a social equity plan later this month (July) outlining how communities which were hit hard during the days of cannabis prohibition can be supported to benefit from the legal industry. This support could include license fee waivers.

On paper, these rules seem logical and practical enough, but the true test will come once their implementation begins later this year before recreational sales begin next year.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The exploding popularity of CBD as a health and wellness product in a largely unregulated market (so far) creates a need for each buyer to vigilant when deciding where to spend their hard-earned money on CBD products. Here are some tips that can help you to sort the great products from those that may not be so great.

Buy from Licensed Dispensaries/Brands

There’s a reason why McDonalds, Starbucks and other major brands attract thousands to their doors each day; buyers are sure that the products they purchase will be of the same quality that they have learned to expect. Similarly, known brands in the cannabis space, such as Golden Developing Solutions Inc. (OTC: DVLP) and Geyser Brands Inc. (TSX.V: GYSR), go to great lengths to provide high-quality products. Consequently, you stand a high chance of getting the best CBD products if you shop from such establishments when compared to another person who takes their chance with any random supplier online or offline.

Scrutinize Online Reviews

Product sellers know that the opinions of buyers matter when potential customers are making a buying decision. Some sellers will therefore do everything they can to tip buyer opinions in their favor, including writing fake reviews. It is therefore helpful for you to read through the product reviews with a critical eye. Do you see many reviews posted at approximately the same time? Are the names or photos of the people who posted those reviews questionable? These may be pointers that the reviews aren’t authentic, so be wary of buying that product. You can also go a step further and use an online tool that ranks sites on how genuine their product reviews are so that you are sure that the reviews upon which you make your buying decision are genuine.

Compare Product Prices

The CBD industry is relatively new, so most manufacturers use the same methods to extract and package products. This means that there shouldn’t be a big variation in the price of comparable products. If a certain product has a price which is significantly lower than the price charged by other sellers, investigate further to ascertain the authenticity of that product. Beware of products whose price seems too good to be true!

Analyze the Product Benefits on the Packaging

While there is still limited scientific research about the health and wellness of benefits of marijuana and its derivatives like CBD, the benefits listed on the packaging shouldn’t be too outlandish either. For example, how will you know that a given product has provided “emotional cleansing” as the package claims? Do your research and only buy products whose stated benefits are realistic given the available information on the subject.

There are indications that the FDA will draft rules to regulate CBD products which are added to food and drinks, and individual states are also drafting their own rules. Until these come in force, the tips above will go a long way in ensuring that you buy the best CBD products available.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Starting from July 1, patients suffering from Alzheimer’s can start enrolling for medical marijuana in Minnesota. Once these patients are registered, they will be permitted to buy medical marijuana from the two licensed manufacturers in the state.

The Department of Health first announced in December last year that Alzheimer’s would be added to the list of qualifying conditions for medical marijuana.

While a review panel had recommended that seven conditions be added to the list, only Alzheimer’s was approved by Jan Malcom, the Health Commissioner. The others which had been proposed include traumatic brain injury and opioid use disorder.

The addition of Alzheimer’s now brings the number of medical marijuana qualifying conditions to 14. This number has been growing every year since the medical marijuana program started five years ago with just 9 qualifying conditions.

Currently, statistics put the number of patients on the state’s medical marijuana program at 15.687 by March 31. The inclusion of Alzheimer’s among the qualifying conditions has the potential to increase the number of registered patients significantly since the Alzheimer’s Association estimates that there are at least 94,000 people who are living with Alzheimer’s in the state. Even if just one tenth of this number signs up for medical marijuana, the patient numbers on the program will swell by a huge percentage.

It isn’t just the Alzheimer’s patients who will benefit when medical marijuana is available. Approximately 254,000 family members and friends are involved in taking care of these patients. When marijuana brings improvements in the behavioral effects of Alzheimer’s, it get easier for caregivers to look after their loved ones.

The Department of Health in Minnesota will use the month of July to process the applications of Alzheimer’s patients and these people will start accessing medical marijuana on August 1. The details of what patients require in order to be certified on the program have been availed on the department’s website.

While no scientific studies have provided any conclusive proof that marijuana can cure, prevent or slow the progress of Alzheimer’s, some recent studies suggest that this could be possible. A small study recently showed that marijuana inhibits the formation of the protein plaque which has been associated with the onset of dementia, one of the leading symptoms of Alzheimer’s.

Minnesota now joins the ranks of states and territories which have included Alzheimer’s among the conditions for which patients may use medical cannabis. Marijuana industry advocates speculate that while the industry players like Earth Science Tech Inc. (OTCQB: ETST) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) may have been disappointed that only one condition was added, they could be pleased that thousands of patients and their families will benefit from medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Colorado Gov. Jared Polis (D) launched an online tool on Monday that will enable members of the public to keep track of what the state government is doing to attain its goals, which include taking the marijuana industry to greater heights.

The goals have been categorized into six groups. These are marijuana, education and workforce, criminal justice, tax reform and economic development, and energy and renewables.

The online tool, called “the governor’s dashboard,” outlines targets or priorities for each of those six areas. For example, under the cannabis category, the governor undertakes to operationalize the home delivery of marijuana in accordance with the law he signed last month. He also promises to see marijuana companies listed on stock exchanges, as well as working for a 20 percent increase in the number of financial institutions serving cannabis companies. Gov. Polis also wants to establish the state as a national leader in research, production and processing of industrial hemp.

Speaking at the launch of the dashboard, the governor revealed that he is happy to avail that platform since it will ensure accountability and transparency on all matters affecting Coloradans.

The agriculture department will do a lot to facilitate the attainment of the goals on hemp. A three-year development plan for this sector shows that the governor wants to see the indoor production of hemp increase to 10 million square feet from the current 7.67 million square feet. The plan also states that outdoor cultivation should increase to more than 60,000 square feet from the current 21,000 square feet.

To attain these lofty goals, the state plans to submit a plan for the regulation of hemp to the U.S. Department of Agriculture for approval so that large scale production can begin. The state will also support farmer-owned cooperatives in addition to other interventions to encourage industrial hemp value addition.

Polis has always believed that the marijuana industry is yet to reach its full economic potential in Colorado and he has done what he can to promote the industry. For example, he signed bills to allow social consumption sites and regulate home delivery of marijuana products.

Last month, the state government released a report showing that more than a billion dollars had so far been collected by the state as cannabis taxes, fees and other collections. It is therefore expected that the working group formed to steer the state towards attaining all the goals listed on the dashboard will not have any excuses for not doing the work assigned to them.

Industry analysts can only guess how far players like ChineseInvestors.com Inc. (OTCQB: CIIX) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) would be if all the markets they operated in were as proactive as Colorado.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A major Congressional subcommittee plans to hold a hearing next week on ending cannabis prohibition. The Crime, Terrorism and Homeland Security Subcommittee will discuss a number of proposals that are aimed at passing legislation to protect states which have enacted marijuana laws.

Considering the list of people who are expected to be invited to speak to the subcommittee on Wednesday (July 10), one is left to conclude that the subcommittee is interested in learning how prohibition can be ended rather than gathering views on whether reform should happen.

For example, one of the witnesses who is expected to testify during the subcommittee hearing is Malik Burnett, a leading physician at the Bloomberg School of Public Health at Johns Hopkins Hospital. Previously, Burnett worked with the Drug Policy Alliance as its National Policy Advisor. In that role, he helped to secure success for a voter initiative to legalize recreational marijuana in Washington, D.C. in 2014.

Marilyn Mosby, the Baltimore State Attorney, is also on the list of those to testify. She is noted for announcing in January this year that her department would no longer prosecute any marijuana possession case.

David Nathan, a doctor and board president of Doctors for Cannabis Regulation (DFCR) is also set to make an appearance before the subcommittee. DFCR is a pro-legalization group of physicians.

As you can see, the people who are lined up to talk to the subcommittee all share a desire to see the end of marijuana prohibition.

While the legislators will not be voting on any specific bill, it is nonetheless an important hearing since it marks the most important Congressional sitting on matters of marijuana policy reform. The information that they gather is expected to be passed on to the powerful House Judiciary Committee under which this subcommittee falls.

The importance of this committee explains why Rep. Earl Blumenauer (D-OR) earmarked that committee as the one that will deliver the end of prohibition in his roadmap to cannabis legalization.

Worth noting is the fact that every Democrat on the full Judiciary Committee cast his or her vote in favor of the recent amendments preventing the Justice Department from taking action in states where marijuana laws have been passed. Six Republicans also cast their votes in support of the spending riders, and this is regarded as a positive sign that broader cannabis law reform can win bipartisan support in this crucial House committee.

It is widely expected that the entire cannabis industry, including entities like Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS), will be keenly following what transpires in the subcommittee.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Back in 2016, voters passed a measure to legalize recreational marijuana in Maine. Since then, residents have been waiting for the state government to draft and pass regulations which would operationalize recreational cannabis cultivation, manufacture and sales. Gov. Janet Mills has now signed the regulations and brings the long wait to an end.

These guidelines will take effect in September and the first recreational cannabis sales could begin early next year.

Speaking at the signing ceremony, Gov. Mills remarked that the rules show what can happen when the government works with legislators, industry players and members of the public to attain a common goal. She added that this law brings the state ever so close to making the people’s wish of legalizing recreational marijuana a reality.

One of the clauses in the regulatory framework states that any marijuana company which wishes to be licensed in the state must have a resident who has lived in Maine for at least four years as the majority shareholder with an ownership stake that isn’t less than 51 percent. This requirement will remain in force until June 2021.

The law also contains restrictions on who can sell marijuana in the state. Anyone who has been convicted for any offense related to drugs (even if that drug isn’t marijuana) within the past 10 years and those who have ever had their marijuana license revoked anywhere in the U.S. aren’t eligible for a marijuana sales license in Maine.

Local authorities have also been allowed to decide whether recreational marijuana businesses can open within their jurisdictions or not. So far, only a paltry 15 out of the 455 municipalities in the state have expressed interest in licensing recreational cannabis businesses.

This low interest is understandable from two key perspectives. First, the ballot measure which saw the legalization of marijuana was passed by a slim majority of voters. If voter sentiments haven’t changed much since 2016, it is reasonable to expect that a sizeable number of municipalities (and the residents therein) will be opposed to recreational marijuana.

Secondly, many municipalities have been waiting on the state government to pass the regulatory framework before they can decide whether to opt in or out of the recreational industry. Now that the rules are out, the vast majority of municipalities in this category will make their position known by the time recreational sales officially begin.

Marijuana industry watchers are wondering what industry players like Youngevity International Inc. (NASDAQ: YGYI) and Willow Biosciences Inc. (CSE: WLLW) think about this regulatory framework, which has become law in Maine.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Approximately three months ago, New Mexico governor, Michelle Grisham signed a marijuana decriminalization bill into law. That law officially took effect yesterday July 1).

In that law, the possession of up to half an ounce of cannabis is no longer a crime punishable by jail time. Instead, the person pays a $50 fine. The punishments for possessing drug paraphernalia have also been reduced.

This law makes New Mexico the 24th state to decriminalize marijuana. Hawaii appears set to enact a similar law soon after the governor revealed that he will not veto a decriminalization bill if it is brought to his desk.

While pro-marijuana advocates were happy that the decriminalization bill was signed into law in New Mexico, they were still disappointed that broader legalization didn’t happen during this session of the legislature. Gov. Grisham had promised to make this happen when she was campaigning for office.

The passing of the decriminalization law doesn’t, however, mean that the governor has reneged on her promise to see marijuana legalized in the state. Last week, Grisham announced that she had formed a working group charged with studying legalization in other states and give her a report about the best way to handle legalization next year.

New Mexico isn’t alone in that club of states whose legalization plans failed this year. New York State was also on the brink of passing a legalization law, but disagreements over how to implement the recreational marijuana program resulted in the state budget for the next fiscal year being read without recreational marijuana in it, and then legislators ran out of time to hammer out a final deal on legalization before the end of the legislative session. Legalization now appears to be farther away than it has ever been.

In lieu of the legalization law, New York legislators passed a decriminalization bill which will see the possession of up to two ounces of cannabis being punished by a $200 fine instead of serving a custodial sentence.

Another failed legalization attempt happened in New Jersey where lawmakers suddenly called off a senate vote on the matter when it became apparent that support wasn’t sufficient to see the bill through. Not even the last-ditch efforts of the governor and legislative leaders could swing more votes in the senate. Now advocates seem resigned to taking the matter to voters in 2020.

Illinois was the one bright example for advocates after the legislature passed a broad legalization law which will be the model for marijuana social justice for years to come. Recreational cannabis will be available on January 1, 2020, across the 11th state to legalize marijuana.

Cannabis industry commentators think that the entire industry, including participants like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and VPR Brands LP (OTC: VPRB), will heave a sigh of relief that New Mexico has provided some good news to break the chain of legislative disappointments.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As Canadians countdown to the start of cannabis edibles sales in December, some sobering information is filtering in to the effect that life insurance premiums could go up depending on one’s cannabis edibles consumption habits.

When recreational marijuana was legalized in October 2018, most insurance companies stopped regarding marijuana users as smokers. People who are categorized as smokers can pay up to four times more in life insurance premiums when compared to those who are categorized as non-smokers. This is because smokers are seen as being higher-risk clients for insurance companies.

However, it has emerged that one’s marijuana consumption habits can still get that person in the smokers’ category when taking out a life insurance policy.

Different insurance companies have their own cannabis consumption threshold beyond which the individual is classified as a smoker. Many put the weekly consumption cap at 2-4 times, but some have a higher consumption threshold.

So, what’s the deal with cannabis edibles and life insurance premiums?

It is anticipated that marijuana edibles will appeal to a broader section of the Canadian community, including those who are queasy about smoking cannabis flower. Additionally, it will be easier for someone to consume an edible product, such as a brownie, containing cannabis since these products will become readily available.

For example, many will not find any problem consuming at least one cannabis edible each day, and it is rational to expect lots of Canadians to consume more than one pot edible a day. This puts their weekly average consumption at more than the threshold set by insurers, and the smoker classification can get activated for such people.

Since marijuana has only been recently legalized, insurance policies are still in their infancy and the fine print hasn’t yet been adjusted to cater for the actual quantity of marijuana consumed. For example, a small brownie containing a small amount of marijuana is currently rated the same as a jumbo one having much more marijuana than what is contained in the smaller brownie.

This seems unfair to marijuana users, but it is what it is until the policies are modified to accommodate those nuances.

Some people may be wondering how life insurance companies will get data on their clients or prospective clients’ cannabis consumption habits. While these insurers will not access your cannabis products purchase records, they will ask you to provide some information about your marijuana consumption habits as you take out a policy.

If you downplay how much marijuana you consume in order to avoid being classified as a smoker, you face a high risk of any insurance claim you or your loved ones make being denied if the insurer later discovers, from your medical records for example, that you consume way more marijuana than what you declared. A discussion with your attorney is advisable before you sign any life insurance paperwork.

These developments in Canada paint a picture of what could happen in the U.S. if the federal government ever amends its marijuana policies to become more permissive towards the substance. How would this insurance issue play out? It would be enlightening to know what the take of marijuana industry players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) is on this matter.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A bipartisan group of senators introduced legislation on Thursday (June 27) intended to facilitate federally-approved research into cannabis and its derivatives, such as cannabidiol (CBD).

The first section of the bill centers on the process through which research institutions can apply to the federal government for authorization to conduct marijuana research. If the bill passes in its current form, the U.S. attorney general would have a maximum of 60 days within which to approve the applications for cannabis research or request the applicant to avail more information.

The first section of the bill also creates a mechanism through which research organizations can get expedited approval if they want a larger quantity of Schedule I drugs, such as marijuana, for their research activities. Currently, the approval process takes a very long time and virtually renders research a near impossibility.

This section of the bill also deals with the process through which entities can apply to become manufacturers of research-grade marijuana products. At the moment, the University of Mississippi has the only federally-approved manufacturing facility across the U.S. The bill seeks to impose a 60-day deadline on the Department of Justice to approve manufacturing applications or ask the applicant to provide supplemental information.

The second section of the draft legislation focuses on the Federal Drug Administration (FDA) and how it approves drugs derived from marijuana. To encourage innovation in this area, the bill seeks to allow any accredited medical or osteopathic institutions, schools, practitioners and manufacturers who have been registered to have access to Schedule I drugs to start growing their own marijuana for research purposes.

The bill also has a provision which gives the Drug Enforcement Administration authority to scrutinize and approve applicants who wish to manufacture any approved drug that is derived from marijuana. These approved manufacturers would also be permitted to import any marijuana products that they deem necessary for doing cannabis research.

Sen. Brian Schatz (D-HI), one of the sponsors of this bill, commented that there is a lot of anecdotal evidence about the therapeutic benefits of marijuana and its derivatives, but the country cannot rely on anecdotal evidence to make policies about the treatment of health conditions. He added that the bill is intended to remove the barriers that make it difficult for the needed research to be conducted to ascertain the truth in the claims regarding marijuana’s medicinal effects.

The 22-page bill has been endorsed by a number of mainstream medical associations, such as the American Medical Association, American Academy of Pediatrics, American Society of Addiction Medicine and American Psychological Association. Several pro-marijuana advocacy groups, such as NORML and Americans for Safe Access have also voiced their support for this draft legislation.

Marijuana industry analysts think that the entire cannabis industry, including players like Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF), will be keeping its fingers crossed hoping to see this bill become law.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the first half of this year comes to an end, you may be wondering what trends have firmly established themselves as shapers of the cannabis industry. Here is an overview of some trends you may have noticed or need to watch going forward.

Trend #1: Growth of Marijuana Social Consumption

It was always ironical that while marijuana was legal in various jurisdictions, it remained nearly impossible to legally use pot outside one’s home. A new wave of amendments and laws is addressing this gap and we have started seeing states and cities creating regulatory mechanisms for marijuana social consumption lounges. Expect these places to spring up in all jurisdictions where recreational marijuana is legal.

Trend #2: Revived Interest in Plant-Derived Remedies

The growth of the cannabis industry may have had an unforeseen consequence of reigniting people’s interest in treatments that tackle health complications from the root rather than just fixing symptoms. Throughout the U.S. and across the world, plant-derived medicine is seeing a revival which may just be what the marijuana industry needs to go to the next level. The CBD craze is one result of this trend. Expect to see numerous formulations from full-spectrum marijuana and hemp at a hospital or wellness center near you!

Trend #3: Remorse for the War on Drugs

There seems to have been a lot of soul-searching going on and the desire to correct the wrongs committed against racial minorities during the failed war on drugs has become a strong driver of marijuana legalization and decriminalization efforts. Illinois has set the bar, but don’t be surprised if other states raise it higher during the next wave of recreational marijuana legalization initiatives.

Trend #4: Consolidation Within the Industry

This was first noticed last year, but it appears to be gathering momentum as this year progresses. As the cannabis industry matures, many mom and pop or small startups in the industry are being gobbled up by bigger players who have the financial and other resources to successfully navigate the complexities of the industry brought by the contradictory state and federal laws. One advantage of this consolidation is that it will promote the industry further since Americans have generally grown to put more faith in big brands across all industries.

Trend #5: Cannabis Flower is Peaking as a Product of Choice

Cannabis flower still takes the lion’s share of the cannabis market, but this year has seen other segments registering massive growth that outstrips the rate at which the market for smokable flower is growing. For example, marijuana oils and edibles have seen explosive growth in recent months, and this surge is likely to continue at the expense of cannabis flower. Several reasons, such as the stigma associated with smoking marijuana, account for the growth of the other product lines.

Current and potential investors in the cannabis industry may be well advised to watch the trends above carefully and make their investment decisions accordingly. It would be interesting to hear what industry participants like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Sugarmade Inc. (OTCQB: SGMD) have to say about the trends above.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A notice from the U.S. Department of Agriculture published in the Federal Register at the beginning of this week provides insights regarding the department’s plans to release rules that will govern the newly legalized hemp industry.

Of particular importance is the August self-imposed deadline when the final draft rules will be released by USDA. Previously, the department had been noncommittal about when it would finalize these rules. They would simply say that the rules will come out in time for the planting season of 2020.

A USDA spokesperson revealed that the August deadline reflects the best-case scenario, but the process of approving those rules will determine the actual date when they would be published in the Federal Register. This approval process seemingly entails getting the nod from other sister federal agencies.

Under the 2018 Farm Bill, states were empowered to pass their own hemp laws and submit them to the USDA for approval before they start being implemented. So far, the Department of Agriculture has revealed the basics of what they expect to see in the state regulations submitted for approval.

Those requirements include product testing standards, annual inspection and certification requirements, disposal procedures as well as law enforcement compliance measures.

These updates come approximately half a year from the time hemp was descheduled by the federal government with the enactment of the Farm Bill of 2018. There has been sustained pressure on the Department of Agriculture to release its rules but the department had remained evasive on when that would happen.

The notice in the Federal Register therefore comes as good news to all interested parties since it shows that the department has been busy ever since it revealed in March that it had started a process through which information would be gathered to shape the rulemaking exercise.

Until the rules are published, it will be hard for large-scale cultivation of hemp to begin across the country. This is because any company or individual wishing to grow or process the crop must adhere to the rather restrictive hemp rules in the 2014 Farm Act which only catered for research-focused hemp activities.

As the USDA works on the draft rules, they have provided clarification that it is now legal to import hemp seeds, transport hemp products across state lines and also submit intellectual property applications to the department even before the rules are released.

Marijuana industry analysts believe that the entire industry, including companies like Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING), should be relieved now that the veil of uncertainty has been removed regarding when hemp industry rules would be released by the USDA.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Rising hemp production is putting pressure on processing.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a provider of cultivation equipment, is adding processors to its catalog of products, focusing on next-generation machinery. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) will be among the companies with a rising demand for processing, as it increases both its cultivation capacity and its product lines. Demand is rising in part thanks to CBD’s public profile, with deals such as the partnership between Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) and UFC shining a spotlight on the plant and its potential. New uses for CBD are also increasing demand for the plant, with R&D led by companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) and Aphria (NYSE: APHA) (TSX: APHA).

To view the full editorial, visit http://cnw.fm/l7Elg

To hear the CannabisNewsAudio version, visit http://cnw.fm/FrH32

About Sugarmade Inc.

Sugarmade Inc. is a product and brand marketing company investing in products and brands with disruptive potential. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Newly released federal data shows that in 2019, more credit unions and banks have been taking on marijuana businesses as clients compared to previous quarters and years.

The federal data shows that there were 113 credit unions and 438 banks which actively serviced cannabis businesses in the final quarter of 2018. The statistics for the first quarter of 2019 indicate that the banks increased to 493 while credit unions numbered 140.

The data comes from the Financial Crimes Enforcement Network (FinCEN) of the Treasury Department. FinCEN tracks the finances of the marijuana industry in accordance with the banking guidelines issued in 2014 by the Obama administration. Under these rules, financial institutions are required to file Suspicious Activity Reports (SARs) with FinCEN.

Under the current federal laws, banks risk being penalized if they do business with cannabis firms since marijuana products are still federally illegal. Despite this risk, more financial institutions are biting the bullet and accepting marijuana businesses as customers.

The update from FinCEN for the quarter ending March 31 shows that they received 81,725 SARs from banks and credit unions across the country. Of those, 61,036 SARs were categorized as “marijuana limited.” This categorization is given to SARs which refer to banking transactions of businesses that comply with state laws.

Another 6,000 SARs were grouped under “marijuana priority.” SARs in this category show transactions that raise at least one red flag due to the transgression of either state marijuana laws or federal guidelines on which sorts of marijuana businesses can be serviced at state level.

20,000 SARs were labelled “marijuana termination.” These are transactions that show that a given business violated either state or federal marijuana laws thereby prompting the bank or credit union to terminate its relationship with that marijuana business.

Financial institutions have for long complained about the complex reporting requirements which they have to comply with while servicing legal marijuana businesses. Those reporting requirements make access to banking services expensive for legitimate cannabis businesses since the costs of compliance are passed on to them.

The SAFE Banking Act which is making its way through Congress is seen as one way to get a lasting remedy to the issue of cannabis banking. This bill is widely expected to be up for a vote on the floor of the entire House of Representatives next month after it was passed in March by the House Financial Services Committee.

In the meantime, Congress voted to include language in the appropriations bill for Fiscal Year 2020 barring the Department of Justice from taking marijuana enforcement action in states and territories with recreational and/or medical marijuana laws.

Codifying these protections into law would go a long way towards easing the fears of financial institutions regarding working with marijuana businesses. Marijuana industry watchers strongly believe that the industry, including players like Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FRA: O3X4) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), will be glad that the federal data shows that more financial institutions are warming up to the marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The National Sheriffs’ Association (NSA) has passed a resolution calling on the federal government to reschedule marijuana. The same resolution also reiterates the group’s opposition to the legalization of recreational marijuana.

In the resolution, the NSA states that they regard the legalization of cannabis as a threat to public safety and health, but they also have empathy for people who are suffering as a result of debilitating conditions which prompt them to seek medical cannabis.

The sheriffs reaffirmed that they remain opposed to not just state-level legalization but decriminalization as well since these policies haven’t done much to eradicate illicit cannabis sales in the states with decriminalization or legalization policies.

However, the group urged the federal government to move marijuana from Schedule I to Schedule II of the Controlled Substances Act in order to make it possible for research to be done into the potential therapeutic applications of marijuana.

The resolution goes on to state that because of statutory and regulatory barriers imposed by the federal government, it hasn’t been possible to obtain any definitive scientific data regarding the therapeutic claims attributed to marijuana. The same barriers have also made it hard to perform research to quantify the cannabis levels which result in impairment.

The sheriffs consequently resolved that marijuana be reclassified to Schedule II so that all the impediments to research are removed.

While the resolution shows that the sheriffs are still opposed to marijuana legalization, their position shows that the organization has undergone a transformation from the last time they voiced their opinion on marijuana in 2015.

Their resolution at that time contained a flat rejection of any form of marijuana legalization, be it medical or recreational. In fact, they urged Congress to do everything possible for the federal government to enforce the Controlled Substances Act.

The recent resolution therefore indicates that the association recognizes, however grudgingly, that marijuana could have some medicinal benefits and they want research to be done to confirm those benefits. This explains why their resolution makes reference to the scheduling of marijuana and yet their 2015 resolution was silent in this regard.

The resolution of the NSA comes at a time when numerous groups and associations, such as attorneys general, banking associations, state governors, and city and local authorities have all passed resolutions or written to Congress urging the federal government to implement marijuana law reforms. Analysts are wondering how industry players like Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) and Net Element Inc. (NASDAQ: NETE) will react to the resolution of the NSA.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

It’s no real surprise that the 6th Annual NCIA Cannabis Business Summit & Expo has made the list of “essential conferences for meeting everyone you need to know to succeed in cannabis.” During its run, attendance at the trade show has climbed exponentially. This year, over 10,000 attendees are expected to congregate, July 22-24, at the San Jose McEnery Convention Center in San Jose, California. Such a crowd of executives, entrepreneurs and investors offers networking opportunities galore. The event, which focuses on business opportunities in the fast-developing cannabis space, undoubtedly offers a matchless opportunity to “meet… everyone you need to know to succeed in cannabis.”

The “essentials” list compiled by industry journal Green Entrepreneur tags the 6th Annual NCIA Cannabis Business Summit & Expo as “great for all things science and technology,” and business, too, might have been added. The National Cannabis Industry Association (NCIA), is devoted to…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

According to a press release issued by the Idaho Cannabis Coalition on Tuesday (June 25), the group has submitted the required list of voters supporting their petition to see medical marijuana included on the state ballot in 2020.

The group was told that they needed to collect a minimum of 55,057 signatures from Idaho voters if they were to be given the go-ahead to put together a ballot measure that would be voted on during the upcoming elections in 2020.

The coalition duly collected the signatures and submitted them to the Secretary of State for verification before the next step of the process can begin.

The chief petitioner of the Idaho Cannabis Coalition is 77-year old John Belville. Speaking at the press conference at the steps of the state Capitol, Belville revealed that he has been taking prescription opiates for his neuropathic pain and those opiates have caused his organs to start failing.

Belville’s son, Russ, was also at the press conference and stated that his father visited him in Oregon and tried medical cannabis while there. It helped him a great deal, and that was why they were campaigning to have this form of treatment legalized in Idaho.

The different speakers at the press briefing affirmed that there were several scientific studies showing the effectiveness of marijuana in treating various conditions. 33 states have acknowledged this and legalized medical marijuana, and there is no reason why Idaho should continue to lag behind, the speakers concluded.

The advocates want to give Idahoans a chance to legally access whole-plant marijuana and other marijuana products from dispensaries which are regulated by the state. The initiative also wants patients with demonstrated financial or physical hardships to be allowed to grow a few plants for their own use instead of having to buy finished medical marijuana products that may be too expensive for them.

The coalition now awaits feedback from the state regarding the status of the signatures submitted after which a program for campaigns on the matter will be drawn.

In 1996, California made history by being the first U.S. state to legalize medical marijuana. Since then, a total of 33 states, as well as the District of Columbia, Puerto Rico, Guam and the U.S. Virgin Islands have legalized medical cannabis. Many more states are in the process of getting medical marijuana legalized either legislatively or through voter initiatives.

Marijuana industry analysts believe that the entire industry, including players like Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) and MustGrow Biologics Corp., will be watching the developments in Idaho closely to see how they pan out.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As had been widely expected, Gov. J.B Pritzker yesterday (June 25) signed a bill legalizing recreational marijuana in Illinois. This makes the state the 11th to legalize marijuana fully, joining the likes of Colorado and California.

When this new law takes effect on Jan 1, 2020, adults 21 and older will be allowed to possess up to 30grams of marijuana and non-residents will be permitted to possess a maximum of 15grams.

The signing ceremony marked the fulfillment of a pledge Gov. Pritzker made when he was campaigning for office. He promised to see the swift legalization of recreational marijuana in order to bring needed revenue to the state, correct historical wrongs occasioned during the futile war on drugs and also shift scarce law enforcement resources to more serious crimes.

This law makes Illinois the first state to legalize recreational marijuana legislatively while creating a comprehensive framework for sales across the state. The other state (Vermont) which took this path just stopped at passing a law that created an agency to work out the details of full implementation.

Until legal sales start at the beginning of 2020, it will still be illegal to possess marijuana unless one is registered on the state’s medical marijuana program.

On the market side, the legalization law creates a first-of-its-kind mechanism through which people from impoverished communities will be helped to participate in the legal cannabis industry. This help will come in the form of fee waivers, low-interest loans and other forms of preferential treatment for “equity” applicants. A portion of all revenue generated from the marijuana industry will also be reinvested in impoverished communities in order to revive their economies.

Police departments have been jittery ever since the law was drafted, and their stiff opposition led to the dropping of a provision which would have seen residents allowed to grow up to five plants for recreational use. This opportunity now went to medical marijuana cardholders who weren’t initially allowed to grow marijuana for their own use.

Police departments are now worried that it will be hard for them to stay on top of people driving under the influence of marijuana since there isn’t reliable technology to test for impairment.

Meanwhile, hopes were high among advocates that New York and New Jersey would also legalize marijuana legislatively this year but the plans in those states fizzled out during spring. There is almost no doubt among cannabis industry analysts that the whole industry, including Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), has heaved a collective sigh of relief that the momentum of state-level legalization hasn’t stalled completely.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Rising hemp production is putting pressure on processing.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a provider of cultivation equipment, is adding processors to its catalog of products, focusing on next-generation machinery. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) will be among the companies with a rising demand for processing, as it increases both its cultivation capacity and its product lines. Demand is rising in part thanks to CBD’s public profile, with deals such as the partnership between Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) and UFC shining a spotlight on the plant and its potential. New uses for CBD are also increasing demand for the plant, with R&D led by companies such as…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

The legal marijuana industry in California has been grappling with a number of challenges, chief of which is how to stamp out the illicit operators in the state. On Friday, the state launched a public campaign aimed at educating the public about the dangers associated with cannabis from the black market.

The “Get #Weedwise” campaign is intended to encourage people to only buy marijuana from the regulated market. The campaign will also send out warnings to the illegal operators to either get licensed or close shop.

In a press release, the Bureau of Cannabis Control (BCC) chief, Lori Ajax, said that this campaign is the first of its kind and it will educate members of the public about the differences between the weed obtained from licensed operators and that from the illicit market.

For example, the BCC will tell people that marijuana from licensed sources has been tested to ascertain its potency, purity and safety. In this regard, one of the ads states that “What is in your weed shouldn’t be a mystery. Buy legal cannabis only.”

The multilingual messages used in this campaign will be disseminated using a variety of methods so that the information reaches “as many eyeballs as possible.”

Many of those messages will be beamed out on digital platforms telling consumers that the marijuana on the black market is potentially tainted with fecal matter, pesticides and mold.

Businesses will also be reached during this campaign. Messages will be sent out warning that cash and illegal goods will be seized if those unlicensed businesses continue operating. The campaign will also provide an expedited way for illicit businesses that wish to become legal to get licensed.

This public campaign is expected to cost at least $1.7 million. More money will be injected into the “Get #Weedwise” campaign as time goes by.

This public campaign comes at a time when there are ongoing battles between the state and local authorities which have not only banned the opening of cannabis businesses within their jurisdictions but are also trying to block the delivery of cannabis from areas where businesses exist.

The few local authorities which have allowed cannabis businesses to operate are choking under the weight of illegal operators. This is the very reason why licensed operators in Los Angeles have formed a coalition to put pressure on the state government to act more decisively against the black market operators.

The step taken by California is likely to be welcomed by all in the industry, including players like Hemptown USA and Green Hygienics Holdings Inc. (OTCQB: GRYN) since it will help to bring marijuana further into the mainstream.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As bugs get more resistant to the existing antibiotics, researchers are looking for new ways to combat infections and cannabidiol, a marijuana compound, is showing promise as a remedy for superbugs.

A new study conducted by researchers in Brisbane, Australia has shown that CBD has promising antimicrobial activity against some strains of Gram-positive bacteria, such as varieties of strep and staph bacteria.

In the study, a synthetic form of CBD was placed in lab dishes containing the bugs being investigated. The cannabis compound showed the same level of antimicrobial activity as two existing prescription antibiotics (daptomycin and vancomycin). The synthetic CBD even went as far as killing some strains of strep and staph bacteria that no longer responded to the two prescription antibiotics.

Additionally, the synthetic compound also acted against bacterial biofilms. These biofilms are formed when proteins are secreted by bacteria on surfaces. Such surfaces can become slippery, and the resulted infections are very difficult to treat. The in vitro tests showed that CBD can combat such biofilms.

The researchers have cautioned that people should not start treating themselves against infections using CBD since this research was an in vitro (in test tubes) study and the findings aren’t a guarantee that similar results will be observed in humans.

Mark Blaskovich, the lead author of the study, said that people are better off sticking to the current treatment options against infections until such a time when their preliminary research findings are pursued further and confirm that CBD works effectively to fight infections in humans.

The study was conducted as a collaboration between Botanix Pharmaceuticals (a drug discovery company) and the Center for Superbug Solutions at the University of Queensland in Brisbane, Australia.

While the research is yet to be published in a peer-reviewed journal, it was presented on June 23 to the American Society for Microbiology during its annual meeting in San Francisco.

It is still early days before CBD is developed into a drug for infections. As already mentioned, further research is needed to establish at what dosage CBD can combat infections in humans, how best to administer the compound for maximum effect, and what side effects, if any, may result from the use of CBD as an antibiotic at the therapeutic dosage established.

The authors of this study are now set on conducting animal studies on the antibacterial activity of CBD while Botanix Pharmaceuticals has set its sights on studying whether CBD can be used to kill staph bacteria on the skin of people before they undergo surgery. This step is essential in preventing post-surgical infections.

Industry watchers expect the entire cannabis industry, including players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP), to feel vindicated by the proof emerging about the health benefits of different marijuana compounds.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

While the popularity of cannabidiol (CBD) has been growing, the current price of high-quality CBD oil is so high that it is out of reach for many of the people who need it the most. Draconis Extraction Technology (DET) has come up with a system which will extract crude CBD on an industrial scale and lower the cost of the final product.

The large-scale ethanol extraction process is patented and is set to start being used to avail winterized, full-spectrum de-waxed CBD oil.

Paul Baskis, the person who invented the extraction system says he was driven by a desire to help those who badly need CBD oil but struggle to afford it. He singled out veterans who suffer from different conditions, such as PTSD and anxiety.

Currently, 1,000mg of CBD oil costs $350 on the market and this oil can last approximately 11 days for a person weighing 180 pounds with a recommendation of 5mg for each pound of body weight. How many people can afford such a cost, he wondered.

The technology introduced by DET will make it cheaper for crude CBD oil to be available without sacrificing the quality of the product. Paul Baskis boasts that the crude oil his extraction system will produce is so pure that someone can vape it without seeing any residues in the vape pen.

The other novel thing about this extraction method is that no waste is generated. The oils and waxes removed are also products in their own right. For example, the waxes are sold as raw materials for the cosmetics industry while the pulp is ready to use in the manufacture of bioplastics, paper and fabrics.

The hemp pulp can also be converted into fuel to power the extraction system and the residue from this fuel is a high-quality carbon-based fertilizer.

Max Le Pera, the Vice President of Draconis, explained that the company feels strongly about environmental sustainability and the need for a circular economy in which each section of the company feeds another without causing any adverse effect on the environment.

The example set by DET shows just how far the recently legalized hemp industry can go in terms of offering solutions to the different problems facing the country, such as reviving the economy of rural areas where hemp can be grown.

The unveiling of this new extraction technology must be having industry players like Geyser Brands Inc. (TSX.V: GYSR) and Earth Science Tech Inc. (OTCQB: ETST) imagining how easier things are going to get as more innovators enter the cannabis and hemp space.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

It has been widely reported that marijuana can treat morning sickness, so it isn’t surprising that more women are resorting to cannabis to ease the symptoms of morning sickness during the initial stages of pregnancy. Researchers have found that the number of pregnant women turning to cannabis is higher than it ever was.

The study published in the JAMA journal found that the number of women who use cannabis to deal with morning sickness has more than doubled from just 3.4 percent in 2002 to 7 percent in 2017.

These findings were obtained after analyzing the data collected during the National Survey on Drug Use and Health. The researchers specifically considered the data provided by 4,400 pregnant women as well as 133,900 women who weren’t pregnant.

The study participants had responded to questions regarding their pregnancy status and other questions about their cannabis use habits, if they used cannabis.

This study reveals that women use marijuana for various reasons, both medicinal and recreational. More specifically, the number of women who used marijuana daily or almost daily grew from 0.9 percent to about 3.4 percent.

Notably, the number of women who used marijuana during their first trimester of pregnancy shot up from 1.9 percent to 5.3 percent while those who used the substance during their second trimester rose to 2.5 percent from 0.6 percent in 2002. A similar increase was seen regarding marijuana use during the third trimester (a growth from 0.5 percent to 2.5 percent in 2017).

The researchers noted that while lots of women are turning to cannabis during pregnancy, only a small fraction of those women did so after getting a recommendation from a doctor.

The study also revealed that doctors are uncomfortable recommending marijuana for pregnant women in states where medical marijuana is legal. This reluctance is largely due to the shortage of research on the effects of prenatal marijuana exposure.

In fact, NIDA (the National Institute on Drug Abuse) says the use of marijuana during the first and second trimester of pregnancy has been linked to low birth weight and length, as well as other developmental problems.

The study’s authors emphasized that there is an urgent need to screen all pregnant women for marijuana use and intervene appropriately when risks are detected. The researchers also called for more research to be done to document the effects of marijuana use during pregnancy so that decisions can be made using concrete information on the subject rather than simply asking women to err on the side of caution and abstain.

Analysts think that the cannabis industry, including participants like Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and ChineseInvestors.com Inc. (OTCQB: CIIX), agrees with the researchers on the matter of research-based recommendations regarding cannabis use by different demographics.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As plans to legalize marijuana fully appear to have hit a dead end in the New York State legislature, the lawmakers have agreed to expand the decriminalization of the drug in addition to providing for the automatic expungement of low-level cannabis possession convictions across the state.

On Thursday, Senators agreed to treat the possession of up to two ounces of cannabis as an infraction punishable by a $50 fine instead of regarding it as a crime. This measure marks a huge change in a state where thousands of residents have been caught on the wrong side of the law and been incarcerated.

The agreement on the expungement measure comes as a compromise deal after it became apparent that there wouldn’t be enough support to pass a full legalization measure. While legalization has failed, cannabis industry advocates still regard this approved measure as a step forward for the industry.

The bill passed with a 39-23 vote in the Senate as the legislative session dragged beyond its expected end on Wednesday.

Gov. Cuomo, who a couple of years ago called marijuana a “getaway drug” was all praises for the decriminalization measure. He said the measure will give relief to the thousands snared by the state’s criminal justice system because of marijuana.

This isn’t the first time that the State of New York is decriminalizing marijuana possession. In 1977, the state decriminalized the possession of a maximum of 25 grams. The new bill more than doubles that possession limit.

It should be noted that under the new law, the possession of more than 2 ounces of marijuana is still a crime and nothing has changed regarding smoking cannabis in public. It is still forbidden.

All the same, this limited measure is still a victory because New York has been notorious for its restrictive marijuana laws. For example, under the medical marijuana program which was legalized in 2014, smoking medical marijuana isn’t allowed.

Many Senators who spoke during the hearing on the measure were disappointed that the bill didn’t seek to fully legalize marijuana. They cited the fact that medical marijuana has been legal for years as proof that cannabis has some value, so they couldn’t understand why it still remained illegal in the state.

The legislators are also debating a proposal tabled by State Senator Diane Savino to expand the medical cannabis program from its “current overly restrictive design” to something more accommodative.

Republicans, who are now the minority in both legislative chambers in New York State, made futile attempts to block the decriminalization measure, calling it “harmful to people.” It isn’t yet clear how industry players like Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) and Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) will react to the current cannabis news coming out of Albany.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The House of Representatives has voted to block the Department of Justice (DOJ) from using its funds to enforce federal cannabis laws within states which have passed their own laws regulating recreational or medical marijuana cultivation, consumption and sales.

This measure was one of the several amendments put before the floor for inclusion in the appropriations bill for Fiscal Year 2020. The measure, which expands an existing rider that protected medical marijuana programs, was approved on Thursday by a 267-165 vote.

Marijuana industry advocates are convinced that the vote tally reflects the broad support for marijuana law reform, and this support can be used to effect further reforms of the federal marijuana laws.

A day earlier (June 19), the House had also passed another measure seeking to protect the marijuana laws of Indian tribes. This particular measure was passed through a voice vote without any lawmaker asking for a roll call vote. The rider now makes it to the appropriations bill as well.

Rep. McClintock, one of the sponsors of the measure which was approved on Thursday, wrote a letter to members of the House on the day of the vote reminding them that what was at stake was a question on whether the federal government had any authority to dictate on matters of policy regarding an issue which happens within the borders of a state. In his view, which other members appear to have agreed with from the way they voted, the federal government didn’t have that constitutional authority.

Marijuana Policy Project, Drug Policy Alliance, Cannabis Trade Federation, and other marijuana advocacy groups hailed the decision of Congress as historical and a sign that lawmakers in the House of Representatives are waking up to the fact that marijuana law reform “isn’t just good policy but has also become good politics.”

It has emerged that the makers of the only CBD-derived drug to be approved by the FDA wrote to congressional staff telling them that the spending rider before the House should be defeated since it “could interfere with the DOJ’s ability to carry out its regulatory mandate.” The letter from Greenwich Biosciences was seen as being in bad taste since the “Big Pharma” company wanted to protect its interests at the expense of the interests of the people in states with marijuana-friendly laws.

The measures now head to the Appropriations Committee of Senate for consideration, and it isn’t yet clear whether they will be favorably received there. In the past, this committee has consistently approved the spending rider stopping DOJ from interfering in state-level medical marijuana programs. Now that the new amendments include protections for recreational marijuana, the industry isn’t sure how the Republicans in the Senate Committee will react.

Industry analysts are wondering what players like Youngevity International Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) would say to the senators if they had a chance to talk to them before they vote on the amendments.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has taken a similar path with the acquisition of Newstrike. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is building a positive public profile through releasing educational tools. Aphria Inc. (TSX: APHA) (NYSE: APHA) has expanded the hunt for cultivation licenses to Germany. Meanwhile, companies such as Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) keep releasing new products into the market.

To view the full editorial, visit http://cnw.fm/7IVvk

To hear the CannabisNewsAudio version, visit http://cnw.fm/T0d0X

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://cnw.fm/TCAN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

• Widely known as the “mother of all cannabinoids,” cannabigerol is believed to have multiple benefits and medical applications in areas such as autoimmune conditions, cancer, pain management, inflammation and more
• CBG oil’s market price in the U.S. is currently two to four times higher than the price of CBD oil
• As genetic advances lead to higher yields, CBG looks set to become a prominent part of the cannabinoid market
• Hemptown USA is working to ensure sustainable production of CBG and is positioned to produce about 40 percent of the North American supply of CBG in the near future

Cannabigerol (CBG) ranks among the cannabinoids that will potentially change the future of the cannabis product market. While CBD currently dominates the landscape, scientific advances and genetics could contribute to the rising prominence of CBG in the future.

Currently, the CBG content in most plants is very low – it remains less than one percent. However, genetics programs can boost that concentration and increase extraction yield. One of the companies at the…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

If, as is widely expected, Gov. Pritzker signs a bill that was passed to legalize recreational cannabis in Illinois, the state’s legalization law will be different from all others in several aspects.

First, Illinois will have defied the odds to legalize adult-use marijuana legislatively. All the other ten states have done so through voter initiatives. Lawmakers in New Jersey and New York at one time seemed poised to pass bills legalizing recreational marijuana but intraparty disagreements have torpedoed those plans.

Another way in which Illinois’ law is unique is that it contains provisions which are aimed at promoting social equity in the marijuana industry. The law creates a Cannabis Business Development Fund through which minorities will be supported to join the legal industry. $12million has been earmarked for this fund and a fraction of the fees levied on players in the cannabis industry will go to this fund as well.

Additionally, licensing fees will be lowered for applicants from minority communities who wish to start recreational marijuana businesses. Loans will also be given to these “equity” applicants at low interest rates. This will address the longstanding difficulty that members of these communities have always had when it comes to accessing business loans.

The law also stipulates that at least eight community colleges should offer marijuana business education programs by September 2020. A minimum of five of those colleges should enroll at least half of their students from low-income communities since those are the primary beneficiaries of this provision in the law.

Another unique feature of the Illinois law is that 25 percent of the sales tax levied on recreational marijuana sales as well as 25 percent of all other fees levied in the industry will go towards funding a “Restore, Reinvent and Renew” program through which grants will be given for the purpose of combating violence and revitalizing the communities most affected by the war on drugs.

The lawmakers in Illinois didn’t just talk about social justice and equity; they went all out and formulated a law which spells out exactly how these ideals will be brought to life in the state. This law is certainly going to be a model from which other jurisdictions borrow ideas when formulating their own laws.

One has no choice but to believe that the entire marijuana industry, including Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF), are likely to be pleased by this cannabis news coming out of Illinois.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Columbia Care, a medical marijuana company, has rolled out its own credit card as the cannabis industry struggles to find alternatives to having to deal in cash only.

Just like banks, credit card providers have been reluctant to embrace the marijuana industry because of fears that they would be sanctioned by the federal government since marijuana remains an illegal substance federally.

This has compelled most dispensaries to accept only cash, with ATMs being a frequent sight on the premises of dispensaries. Some dispensaries have designed systems which accept ATM or debit cards for making payments for purchases made.

Columbia Care has been running trials of its credit card in New York and it now plans to roll out this system in Chicago where it has a dispensary within the Jefferson Park neighborhood. Nicolas Vita, the company’s CEO says that patients spend approximately $144 each time they visit the dispensary in Chicago.

He added that the introduction of the credit cards will make it easier for patients to access the medical marijuana products that they need. He singled out patients who have mobility challenges and those who travel long distances to find a dispensary as some of the patients who may buy more products once they have the credit card. Buying more during a single visit reduces the frequency of making trips to purchase replenishments.

To get the credit card, patrons will be asked to use the tablet in the dispensary to fill a form. The credit card will then be processed quickly and the dispensary client will be in position to use that card during that same visit.

Columbia Care revealed that it is working hard to secure intermediaries and financial institutions in all the 12 states where the company has operations. Those partnerships will make it possible for dispensary clients to use the credit card in those other states.

Unlike other credit cards, the one issued by Columbia Care will not attract any fees. Its annual interest rate (15.99 percent) is also lower than the industry average (17.73 percent).

When the credit card was tested in New York, customers bought approximately 18 percent more products when using the credit card when compared to the purchases made when paying cash or using an ATM or debit card.

Other attempts have been made to find alternative ways to receive payments, but some of those methods border on illegality. For example, some companies accept credit cards but the purchases are reflected on credit card statements as spending at a florist’s while other companies ask clients to buy a gift card and then use that gift card to buy marijuana products.

Meanwhile, there has been a recent push by different groups, such as Attorneys General and banking associations, urging Congress to enact legislation bringing marijuana industry money into the banking system.

It would be interesting to know what industry players like Sugarmade Inc. (OTCQB: SGMD) and Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) think about some of the unorthodox payment methods that some marijuana companies have resorted to.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Skepticism has been squashed and all apprehension eliminated. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?

Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Last October Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) soared 60% in one week when the company announced a deal to buy PharmCann. Florida-based Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL) went public last September through a reverse merger in Canada and soared 200% after a strong 2018 Q2. Already up big on Canadian exchanges, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) became the first pure-play marijuana stock to list on NASDAQ around $7 and just bounced off $23 a share. Last year, Tilray Inc. (NASDAQ: TLRY) became the first cannabis company to IPO on the NASDAQ at $17 per share and by September skyrocketed to $300. Despite price surges and fluctuations in the big cannabis names, there’s bound to be more money made in the sector; the run is far from over.

To view the full editorial, visit http://cnw.fm/92nVW

To hear the CannabisNewsAudio version, visit http://cnw.fm/6PpYq

About Wildflower Brands

Wildflower Brands is a Vancouver-based company developing and designing branded CBD experiences that focus on plant-based health and wellness products. All of its brands work in synergy toward becoming a global wellness leader. For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://cnw.fm/WLDFF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

• Cannabis Drinks Expo will offer an opportunity to learn, network and source within the cannabis market
• Industry experts are expected to collectively examine the benefits of the burgeoning cannabis drinks category
• Special pricing on conference tickets ends July 10, 2019

Cannabis Drinks Expo by Beverage Trade Network is on the horizon, providing a gateway to the new legalized cannabis category. Taking place Thursday, July 25, 2019, from 9:00 a.m. to 5:00 p.m. at the South San Francisco Conference Center, the expo is expected to be the first event to give the global drinks industry the chance to convene and look at ways to address legalized cannabis. Drinks producers, manufacturers, brand owners, distilleries and brewers are set to assemble at the expo to discuss and examine ways that they can benefit from this growing category. The Beverage Trade Network (BTN) organizes events for the alcoholic beverage trade worldwide.

A trade-only event, the focus of the Cannabis Drinks Expo is growing businesses and strengthening bottom lines. The event will provide brand owners, distilleries and breweries with the…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The cannabis sector continues its steady shift toward big business and big money, with much of growth based on acquisitions, agreements and consistent research.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) is focused on creating a large operation with various licenses and recognized brands, with several key acquisitions, being part of that strategy. Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) is in the process of acquiring PharmaCann, which recently received an extension to complete the development of its cultivation facility in Ohio. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) just entered into a multiyear supply agreement that will help the company provide high-quality products to consumers in anticipation of the derivative market launching in Canada this fall. Tilray Inc. (NASDAQ: TLRY) recently completed its acquisition of Manitoba Harvest, the largest hemp food company. GW Pharmaceuticals Plc (NASDAQ: GWPH) continues its march forward as a leader in cannabinoid prescription medicines sector with its recent announcement of positive, top-line results of a Phase 3 clinical trial of Epidiolex® in the treatment of seizures associated with…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

On Friday last week (June 14), Gov. Greg Abbott signed a bill that is focused on increasing the number of qualifying conditions for which patients can be licensed to use medical marijuana in the state.

House Bill 3703 gives doctors permission to recommend any patient who suffers from seizure disorders (intractable epilepsy, for example), spasticity, Parkinson’s, multiple sclerosis, autism and several other conditions to access medical marijuana whose THC content doesn’t exceed 0.5 percent from the dispensaries licensed by the state.

Joshua Raine, an Army veteran suffering from post-traumatic stress disorder, is one of the patients who pleaded with legislators to include PTSD among the qualifying conditions for which someone can use medical marijuana.

He told the lawmakers that he has lost more friends (who are veterans) to suicide induced by PTSD than the number of friends he lost during combat operations. He admitted that without medical marijuana, he too could have committed suicide.

Blake Novacek is another patient who is likely to benefit from the enactment of this law. He was attacked violently during a fraternity pledge and that attack caused him to develop seizures. In fact, while waiting to talk to legislators during the debate on the medical marijuana expansion bill, Novacek started convulsing violently as the gravity of his situation showed itself at the state Capitol.

His father (a former Dallas Cowboys player) and mother pleaded to be given a chance to access medical cannabis legally so that they can save the life of their son. In the past, cannabis has helped massively, they added.

Texas is one of the most conservative states in terms of marijuana policy reform. The marijuana program in this state is so restrictive that the only form of medical cannabis allowed is cannabis oil whose THC content is much lower than what advocates say is required for therapeutic purposes.

Nonetheless, advocates are glad that the state has taken this modest step to expand the list of qualifying conditions from the very narrow version which has existed since low-THC cannabis oil was legalized as a form of treatment. Activists hope that more incremental reforms will be enacted until Texas’ medical marijuana program is at par with programs in other states.

Many Texans keep wondering how companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) handle the frustration of thinking that a major decision was made without paying ample attention to the scientific information available but instead unfounded fears took the day.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The effects of the longstanding cannabis shortages in Canada are being felt far beyond the empty shelves in retail outlets. When recreational marijuana was legalized on October 17, 2018, a promise was made that marijuana edibles, vapes, CBD and beverages (so-called cannabis 2.0 products) would be available for purchase exactly one year later. Now the regulator has delayed the start of retail sales of those products citing a procedural requirement for the producers.

Health Canada, the regulator of the marijuana industry in Canada, held a briefing on Friday, June 14 in which the regulator informed the public that there would be a delay in rolling out the “cannabis 2.0” products for another two months.

Health Canada mentioned that while its rules would start being operational on October 17, it wouldn’t be possible for any edibles or other “2.0 products” to be sold until at least two months later. This is because the manufacturers of those products will start filing notices with the regulator of the products being brought to market and those manufacturers must then wait for a minimum of 60 days before starting to ship the products to the retail outlets.

It is believed that the 60-day window will allow the regulator to scrutinize those products and approve those which meet all the requirements in the law. In effect, retail sales will begin on Dec. 17 or thereafter.

The revenue generated from cannabis edibles and other second-generation marijuana products will not be reflected in the earnings of the fourth quarter (Q4) of this year. Instead, those figures will only become meaningful at the end of Q1 of 2020.

Canadian companies like Aurora Cannabis and Canopy Growth had been looking forward to launching the sale of these products because those products have performed excellently in the U.S. states which permit their sale.

These Canadian companies are therefore going to have no choice but to revise their revenue projections for Q4 of 2019 to reflect this delay to bring edibles, beverages and other “second-wave” marijuana products to the market.

On the other hand, marijuana companies shouldn’t be too concerned by the delay unless the cannabis 2.0 products were going to carry a bigger profit margin than the smokable flower which is chronically sold out at retail outlets.

Analysts are eager to know what marijuana industry players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) have to say about this latest announcement by Health Canada.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The cannabis markets have already produced some amazing financial results, but all indications are the industry is only at the beginning of an impressive ascent.

Quarter-over-quarter sales growth is one of the indicators used to indicate upside potential. With that in mind, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) more than tripled its revenues from one year ago, both on a year-over-year and quarter-over-quarter basis, and Scotts Miracle-Gro Company (NYSE: SMG) announced company-wide sales increased 17% in its fiscal second quarter. Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF) grew its first-quarter 2019 revenues by 192% year-over-year to $44.5 million while Acreage Holdings Inc.’s (CSE: ACRG) (OTCQX: ACRGF) first-quarter 2019 performance showed…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

A survey conducted by Gallup has found that the majority of Americans who are familiar with CBD (cannabidiol) want it available as an over-the-counter drug. The results of the survey were released on Friday last week (June 14).

The CBD craze traces its roots to the cannabis reform movement, and it gained momentum when the Farm Bill 2018 became law last year. This bill legalized industrial hemp and all its derivatives, including CBD.

The survey involving 1,017 participants was conducted over the phone in a bid to get insights into the widespread appeal of CBD. The interviews were conducted from May 15-30.

In all, 39 percent of the people polled revealed that they want to see CBD available as an OTC drug while 21 percent said CBD should be accessed using a doctor’s prescription. 36 percent of the people polled revealed that they weren’t familiar with this particular compound of hemp and marijuana plants.

When Gallup focused on those who were familiar with CBD and asked them whether CBD should be purchased as an OTC drug or as a prescription drug, 61 percent favored the OTC option while 33 percent preferred to see it as a prescription drug.

The participants in the poll were also asked to rate how familiar they were with CBD. 14 percent looked at themselves as “very familiar” with it, 33 percent felt they were “somewhat familiar”, 17 percent felt they were “not too familiar” while 36 percent confessed that they “weren’t familiar at all” with cannabidiol.

Gallup again narrowed its attention to only those who categorized themselves as very familiar with cannabidiol and asked them for their opinion about the medicinal value of CBD. 90 percent of this group believed that CBD had therapeutic benefits.

Of those who thought CBD had medicinal benefits, 33 percent said it had “a lot of benefits”, 45 percent felt CBD had “some benefits” and 14 percent thought cannabidiol had “a few benefits.” 3 percent were neutral on the matter while 4 percent said cannabidiol didn’t have any medical benefits.

Commenting about their findings, Gallup wrote that most Americans already believe that CBD has medicinal value even if research has been slow in proving or disproving many of the therapeutic benefits attributed to CBD. Gallup is convinced that the fraction of people who think CBD is medicinal is most likely to grow as more people get exposed to this non-psychoactive compound.

This possibility takes on a greater degree of certainty given that the FDA has already been convinced enough of CBD’s therapeutic benefits to the extent of approving a drug targeting rare forms of epilepsy.

The pressure on federal agencies like the FDA and Congress to pass laws legalizing CBD as a food supplement and other uses is therefore going to increase as the months go by.

Cannabis industry analysts are of the opinion that the Gallup findings didn’t catch industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) by surprise.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The House Rules Committee of Congress is set to hear almost a dozen amendments related to marijuana this week. This crucial committee will decide which of those amendments are cleared for a vote by the whole House. The amendments are being considered this week because those that pass will form part of the appropriations bill for funding sections of the federal government in the next fiscal year.

Rep. Tom McClintock (R-CA) and Earl Blumenauer (D-OR) have reintroduced an amendment intended to prevent the Department of Justice from using its budget to get in the way of states which have enacted their own marijuana laws. An existing spending rider only covers medical marijuana, but the proposed amendment takes this further and seeks to protect state-level recreational marijuana as well. This new amendment is similar to another which failed by just nine votes in 2015.

Another amendment before the committee was introduced by Rep. Stacy Plaskett (D-VI). This measure is intended to correct the inadvertent omission of the U.S. Virgin Islands from the list of states and territories whose medical marijuana programs are protected from Justice Department interference by a spending rider.

Rep. Blumenauer didn’t stop at the amendment he co-authored with McClintock. He also brought several other amendments on his own. One amendment seeks to bar the Department of Justice from interfering in the tribal medical marijuana programs even if the states in which those tribal communities are found haven’t enacted medical cannabis laws. Three other amendments filed by the legislator also protect tribal marijuana programs in various ways.

Two other amendments by Blumenauer touch on the Department of Veteran Affairs. One protects VA workers from being penalized for filing paperwork in compliance with state laws regarding medical marijuana. Another aims at protecting VA doctors from being penalized for any marijuana-related work they do in states where medical marijuana is legal.

The Rules Committee will also consider a measure tabled by Rep. Ocasio-Cortez (D-NY) seeking to divert $30 million from the funding allocated to the DEA. This money should go towards the Comprehensive Opioid Abuse Program. In this way, the DEA will fall in line with the current thinking that drug addiction is a public health concern rather than a crime.

Rep. Jerry McNerney (D-CA) has also tabled an amendment containing a spending proposal for the FDA to undertake a process through which CBD (cannabidiol) will become legal as an additive in food supplements and conventional foods.

It is interesting to note that many of the amendments seem to be geared at introducing marijuana policy reforms using the appropriations process. The success of the spending rider placed on the DOJ years ago appears to have provided an example that advocates want to use to initiate incremental changes to the existing marijuana policies.

Analysts wonder what major cannabis industry entities like Net Element Inc. (NASDAQ: NETE) and Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) think about this change in strategy.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has taken a similar path with the acquisition of Newstrike. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is building a positive public profile through releasing educational tools. Aphria Inc. (TSX: APHA) (NYSE: APHA) has expanded the hunt for cultivation licenses to Germany. Meanwhile, companies such as Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) keep releasing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

The Veterans and Legal Affairs Committee of Maine’s Assembly has voted 7-2 approving the draft rules for the legalization of recreational marijuana in the state. The approved rules relax the residency requirements included with the purpose of keeping out-of-state companies from moving in and controlling the recreational market at the expense of local companies.

The committee removed language that limited out-of-state players from having majority stake in recreational marijuana companies which operate within Maine. In its place, the committee left a provision to the effect that Mainers who have resided in the state for at least four years will have 51 percent ownership of any company to be licensed to conduct business in the recreational marijuana arena. This means that the local ownership can be several individuals or entities as long as their combined stake adds up to 51 percent in the company.

Erik Gundersen, the head of the Office of Marijuana Policy, said his office wants to see the tools which will make it possible for the letter and the spirit of the law to be implemented. He added that the law should be made by Mainers, within Maine and for the benefit of Mainers.

The Maine Office of Marijuana Policy was instrumental in including language which specifically sought to lock out large corporations from using out-of-state management contracts to dominate the local recreational cannabis market in the fashion of what is happening in Massachusetts and even in the medical marijuana program of Maine.

However, not everyone was thrilled with that proposal to lock out out-of-state companies. Some people said that the provision would be counterproductive because it would hurt the interests of Mainers in the long run since the capital and technical expertise of out-of-state operators was needed to kick-start the recreational marijuana industry. They cited the example of manufacturing equipment which costs millions and would be out of reach for most local investors.

Wellness Connection of Maine, the biggest medical marijuana company in the state, had even threatened to sue the regulator if the original text of the bill was retained in the final language of the law. The company felt that the provision about out-of-state companies was targeting it since it has complex management contracts with out-of-state operators.

The time at which marijuana companies should close their doors also generated a lot of debate in the committee. The original bill stipulated that retail outlets should close at 9pm, but this was changed to 10pm to avoid sending people to black market players. Law enforcement agencies had pushed for the 9pm closing time.

The committee decided that local authorities shouldn’t have the right to set their own operating hours for cannabis businesses. However, cannabis businesses could apply to open for extended hours and the regulator would consider their request on a case-by-case basis.

Now that the bill has been cleared by the committee, advocates hope that the entire House will vote on it before the legislative session ends on June 19.

Marijuana industry analysts hope that the cannabis industry, including players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and VPR Brands LP (OTC: VPRB), will be happy that a robust debate was conducted and the strongest arguments won the day during the committee session.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the countdown to the end of this legislative session in New York State enters the final stages, plans to legalize recreational marijuana have been revived with the possibility of a vote on the matter this week.

While momentum to get recreational weed legal appeared to fade once lawmakers in New Jersey announced that they were giving up on trying to use legislative means to end prohibition, advocates in the Empire State are brimming with optimism that lawmakers may have reached a deal and the bill will pass.

Democrats in both the Assembly and Senate held conferences last week in a bid to discuss the fine print of the legislation. Sources close to those who attended these meetings reported that the conferences went well and that the bill may have enough support to sail through.

On Saturday last week, the staff of the legislative leaders in Senate and the Assembly met those from Gov. Cuomo’s office to talk about the final language of the bill which will be put before lawmakers within the last days of the legislative session.

Earlier on Wednesday last week, the senate version of the legalization bill was given the “same as” status indicating that its language was identical to the language of the version in the Assembly. This is an indicator that both chambers agreed on the wording of the bill, and that is an early indicator of possible success when a vote is called.

The speaker of the Assembly, Carl Heastie (D), revealed on Friday that the Democrats hadn’t yet decided on whether to bring the matter to the floor of the House but added that the bill had support among the Democratic members of the chamber. Despite the optimism, analysts think that the bill is still short by two votes in the state Senate.

Sensing that the bill may soon be up for a vote, key state officials have been urging legislators and the governor to include a given list of provisions in the final text of the bill.

Letitia James (D), the State Attorney General wrote that the bill should include provisions to expunge all previous convictions for non-violent marijuana crimes.

NYC Mayor Bill de Blasio (D) also pushed for expungement and added that the bill legalizing recreational marijuana should aim at empowering local businesses rather than big corporations.

The district attorneys of Albany County and Manhattan jointly wrote an op-ed urging lawmakers to end what they called “staggering inequities” and also promote public safety by enacting the bill to legalize recreational marijuana.

The legislative session will end on Wednesday, so lawmakers have a narrow window within which to schedule a vote in both chambers.

Industry watchers have been wondering whether marijuana industry players like SinglePoint Inc. (OTCQB: SING) and Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FRA: O3X4) experience as much tension when a major decision is due as what the people of New York State are experiencing in these final days of the legislative session.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Skepticism has been squashed and all apprehension eliminated. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?

Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Last October Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) soared 60% in one week when the company announced a deal to buy PharmCann. Florida-based Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL) went public last September through a reverse merger in Canada and soared 200% after a strong 2018 Q2. Already up big on Canadian exchanges, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) became the first pure-play marijuana stock to list on NASDAQ around $7 and just bounced off $23 a share. Last year, Tilray Inc. (NASDAQ: TLRY) became the first cannabis company to…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Activists in Mississippi have revealed that they are about to reach the required number of voter signatures in order to see an initiative about medical marijuana included on the ballot in 2020.

Once the organizers submit that list of signatures, the Secretary of State will go through it and certify that each of the signatures belongs to a valid voter in the state. The organizers have emphasized that they will not stop once they reach the minimum number of signatures required. Instead, they will keep gathering more until the submission deadline in September is reached. The extra signatures will serve as an insurance policy just in case some of the signatures collected are deemed invalid. So far, about two-thirds of the required number of signatures have already been collected.

State law requires that if the petition is to be included on the ballot, it must be supported by at least 86,185 registered voters across the state. Additionally, the law also sets minimum numbers of signatures that have to be collected from each of the Congressional Districts in Mississippi.

The initiative for which signatures are being collected seeks to create a law under which patients suffering from debilitating conditions can consult their doctors and obtain a recommendation to use medical marijuana.

22 qualifying conditions, including PTSD, cancer, chronic pain and epilepsy have been suggested as conditions for which patients can use medical marijuana. Patients who get recommendations from their doctors and are registered by the state will be eligible to buy a maximum of 2.5 ounces of medical cannabis within a two-week window.

Currently, the state only allows a limited number of patient categories to use CBD oil to manage their health conditions. This oil has to be purchased from a few highly regulated suppliers whose products have been subjected to rigorous testing at the National Center for Natural Products Research.

The NCNPR is based at the University of Mississippi where the only federally approved manufacturing facility for research-grade cannabis is based.

If the medical marijuana initiative makes it onto the ballot and gets the approval of voters, the Department of Health will be responsible for establishing and regulating a more robust system through which patients can access medical marijuana.

The steps taken to get medical marijuana on the ballot in Mississippi follow the regional trend which has seen several states make marijuana law reforms. Texas has decriminalized marijuana possession and passed a bill to expand its medical cannabis program. Similarly, Alabama’s legislature recently passed a bill to legalize medical marijuana while Georgia also expanded its medical marijuana program.

According to analysts, the positive changes in this region of the U.S. could signal to industry players like MustGrow Biologics Corp. and Marijuana Company of America Inc. (OTCQB: MCOA) that the entire country may soon embrace marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Competitive Enterprises Institute, a libertarian think tank, has claimed in a formal filing that the federal government erred in the way it handled the scientific evaluation of cannabis’ therapeutic value, and the government must therefore take steps to fix the errors it made.

Their request for correction was sent to the Department of Health and Human Services (U.S. HHS). HHS had written to the DEA in 2015 and the DEA relied on that letter from HHS in determining that marijuana be classified as a Schedule 1 drug in the U.S.

According to CEI (Competitive Enterprises Institute), the letter sent by HHS lacked a very important element which is required by federal law. The federal Information Quality Act demands that such “highly influential scientific assessment” as the contents of the HHS letter to the DEA be subjected to a peer review evaluation before the information therein can be relied upon when making regulatory decisions.

No such peer review was conducted, and the CEI is demanding that HHS withdraws its letter to the Drug Enforcement Administration until the requisite peer review exercise has been done as stipulated in the law.

The DEA leaned heavily on the contents of the letter written by HHS to the effect that “marijuana has no recognized medical use in the U.S., has a high potential for abuse and doesn’t have an acceptable level of safety even when used under medical supervision.” Based on this information, the DEA rejected an application which had been made to have marijuana rescheduled in 2016.

In its letter to HHS, CEI points out that various medical associations and a huge fraction of the public in the U.S. have formed a largely different conclusion about marijuana. By law, HHS now has a maximum of 120 days within which to respond to the concerns raised by the Competitive Enterprises Institute.

Devin Watkins, an attorney for CEI, says that the federal government’s policy is likely to change if a reassessment of the matter is conducted. This is especially likely given that 33 states across the country have legalized marijuana for medical use.

The attorney added that the reassessment would be significant in ensuring that government agencies don’t brand uninformed opinions as scientific positions upon which public policies are made. Independent experts can shine a torch on the opinion of an agency and correct it if a mistake has been made.

Industry observers suspect that the entire cannabis industry, including players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Hemptown USA, are likely to follow keenly how HHS responds to the letter written by CEI.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

From the first day of 2020, no employer in Nevada will be allowed to deny a job applicant employment just because that individual tested positive for marijuana during a pre-employment drugs test. The ban is contained in a bill which was signed into law by Gov. Sisolak on June 5. This makes Nevada the first state to enact such legislation in the country.

The new law contains some exceptions for people who may be denied employment on the basis of pre-employment marijuana screening. These include firefighters, EMTs, those who operate vehicles, federal government employees and anyone else applying for a job that the employer deems to be safety-sensitive.

The law also states that when an employer requires a prospective hire to be tested for marijuana, that potential employee has the right to have another test done within 30 days and the employer is bound to accept the results of that additional test. This extra test is at the expense of the prospective employee, according to the newly signed law.

Gov. Sisolak said that he was happy to sign AB132 because the cannabis industry in Nevada was growing and there was need to pass appropriate laws so that all residents of the state remain eligible to take advantage of all the opportunities available. He added that the exceptions included in that law are a matter of commonsense since matters of public safety and transportation have to be taken seriously.

This law has been regarded as long overdue by cannabis advocates since it was naturally expected that positive test results during pre-employment drugs screening would increase after the state legalized recreational marijuana in 2016 and commercial sales started a year later for adults 21 and older.

The law passed and enacted in Nevada is similar to the bill which was passed by the New York City Council in April this year. That bill banned employers from demanding that job applicants pass a drugs test for marijuana as a condition for being employed.

In Maine where recreational marijuana is legal, state law bans employers from discriminating people based on whether they use or don’t use marijuana. However, there is no specific provision banning marijuana testing during the employee hiring process.

Now that Nevada has paved the way, many other states are likely to ask themselves why they hadn’t thought of passing such a law since it is only logical that once recreational marijuana is legal, adults will legally use it and it would be unfair to deny them jobs because they used a legal substance.

Industry commentators would be glad to hear what different companies in the cannabis industry, such as Green Hygienics Holdings Inc. (OTCQB: GRYN) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), have to say about the developments in the cannabis industry in Nevada.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The state of Colorado has now pocketed more than $1 billion in revenue from the legal cannabis industry. This marks yet another milestone for the state which legalized marijuana in 2014.

According to marijuana sales data which has just been released by the state, cannabis sales hit the $6.5 billion mark at the end of May this year. The data also shows that the sales of recreational marijuana are continuing to rise higher as the months roll by.

April and May 2019 have also been the best months so far in the entire history of the cannabis industry in Colorado with the monthly state revenue reaching the highest level ever at $24.2 million in April. The state took approximately three and a half years to reach cannabis sales totaling $500 million, but the state was able to double that figure in less than two years to cross the $1 billion mark.

Since July 2017, the revenue collected by the state from the cannabis industry has never gone below $20 million each month. This shows massive growth given that the total state revenue from marijuana in February 2014 was just $3.5 million.

Speaking at a Net Net event in Denver on May 1, Gov. Polis revealed that the marijuana industry was doing very well because it had created “tens of thousands of jobs, reducing crime, filling up buildings and bringing state revenue.”

Speaking of creating jobs, there are 41,076 people who have licenses to work in the Colorado cannabis industry. It is reasonable to conclude that nearly all those people are indeed employed in the industry since the licenses are renewed every two years and it wouldn’t make sense for someone to pay for and renew a license if they aren’t working in the industry.

Gov. Polis wants to see the cannabis industry take even bigger strides and take full advantage of its trailblazer status across the country. He knows that cannabis sales will never equal those in bigger states, such as New Jersey and California, so he has set his sights on other ways through which Colorado can remain a leader in the industry. For example, he wants to see cannabis point of sale systems, cannabis genetics and cannabis chemistry innovations headquartered in Colorado from where other states are served by those companies.

With sales and state revenues hitting such highs, who would blame the governor for dreaming big? The situation in Colorado is far different from other states, such as California, where the legal cannabis industry is struggling under the yoke of high taxes, a vibrant black market and legal battles with local authorities and cities which have banned marijuana sales in their jurisdictions.

If only one could be a fly on the wall and hear what goes on in the corridors of companies like Golden Developing Solutions Inc. (OTC: DVLP) and Geyser Brands Inc. (TSX.V: GYSR) as they talk about the contrast between what is happening in Colorado and in California!

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Experiments with next-generation delivery systems appear certain to lead to better cannabis-based products.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has recently seen spectacular improvements in the effectiveness of cannabinoids thanks to its proprietary chemical delivery treatment. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF), which has won widespread praise for its innovative medical work, has seen good trial results for a new treatment for seizures.  Tilray Inc. (NASDAQ: TLRY) is supporting studies into the uses of cannabinoids to treat behavioral problems and HIV. MariMed Inc. (OTCQB: MRMD) has set up a subsidiary focused on CBD, currently the highest-profile cannabinoid product. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has established a new research lab to develop devices for CBD consumption.

To hear the CannabisNewsAudio version, visit http://cnw.fm/My9kX

To view the full editorial, visit http://cnw.fm/Od8IU

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Extraction technology plays a crucial part in the production of cannabidiol (CBD) from hemp.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a company already established in the hydroponic equipment business, is making plans to add extraction technology to its repertoire. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has been researching new medical applications for CBD and related chemicals — medicines for which extraction will be critical. KushCo Holdings Inc. (OTCQX: KSHB)has moved from providing support services to CBD-related companies to running its own store and has recently bolstered its leadership team for further growth. Harvest Health & Recreation Inc. (CSE: HARV) (OTCQX: HRVSF) has expanded swiftly over the past six years, growing from a single operation to a presence in five U.S. states. And in a boost to CBD’s public profile, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has teamed up with UFC to research the application of CBD and related treatments for mixed martial artists.

To hear the CannabisNewsAudio version, visit http://cnw.fm/48P8p

To view the full editorial, visit http://cnw.fm/Sai9c

About Sugarmade Inc.

Sugarmade Inc. is a product and brand marketing company investing in products and brands with disruptive potential. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

If you were wondering how fast marijuana could become a mainstream substance, the Church of England has just provided further proof that this once heavily stigmatized plant is getting the recognition and acceptance that it deserves. The Church of England has instructed its number crunchers to start making investments in medical marijuana companies.

In the past, the Church Commissioners for England (the entity which manages the $16 billion investment portfolio of the Church of England) rigidly adhered to their self-imposed policy of not holding stocks in cannabis companies.

The new policy allows the Church of England to hold stocks of medical marijuana companies. Recreational cannabis is still a no-no and any company which obtains more than 10 percent of its revenue from the sale of recreational cannabis is off-limits for the Church of England.

Edward Mason, the head of responsible investment at the Church Commissioners for England confirmed that they “make a distinction between recreational and medicinal cannabis” and are content with marijuana being used for medical purposes. Mason concluded by saying that the Commissioners for England are happy to invest in medicine.

The Church Commissioners for England have a huge reputation for their “ethical” investment decisions. They will only invest in companies which meet their strict definition of what constitutes Christian values. Consequently, the group will never invest in industries of questionable moral character, such as pornography, gambling and tobacco. Marijuana, or at least its medical side, is now acceptable to the group.

The decision by the Commissioners for England to start investing in medicinal cannabis is a huge step forward in the eyes of patients using medical marijuana because it helps to put a dent in the wall of stigma which those patients have to deal with on a daily basis.

Many people regard anyone using cannabis as stoner, even if the person is consuming medical cannabis purely for therapeutic purposes rather than for the recreational purposes. This stigma has compelled patients to resort to hiding while they are taking medical marijuana, and others have restricted themselves to more discreet modes of administration, such as edibles and suppositories.

Medical marijuana patients therefore hope that the step taken by the Church of England is followed by all the other religious denominations. In this way, medical marijuana will get the broad acceptance which it deserves as a form of medicine.

Both laypeople and cannabis industry analysts wonder how the more favorable direction taken by the Commissioners for England regarding medical marijuana will impact the future plans of industry participants like Earth Science Tech Inc. (OTCQB: ETST) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF).

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The legislature in Oregon has voted to approve a law which will see the marijuana convictions of tens of thousands of Oregonians expunged so that those individuals can have a better chance at finding jobs, getting an education and having access to housing.

Senate Bill 420 seeks to clear all marijuana convictions which are no longer crimes from the time marijuana was legalized in the state in 2014. This means people who were prosecuted and convicted prior to 2014 can have their slate wiped clean.

This bill was initially approved by a 25-4 vote by the Senate in April. However, the bill was modified when it was taken to the Assembly, so the modifications were brought back for approval by the Senate. The State Senate repassed the bill with a similar 25-4 vote. What is now left is Gov. Kate Brown’s signature so that the bill becomes law.

It isn’t immediately clear how many people are eligible to have their criminal record wiped. This is because in the past, court records didn’t reflect the specific controlled substance that an accused person was charged with.

However, estimates put the number of people who were convicted for marijuana possession at about 20,000-75,000 individuals.

Once this bill becomes law, anyone who was convicted for a marijuana crime that is no longer in the law books can fill out a form asking to have their conviction expunged.

Sen. Lew Frederick (D-Portland) supported the bill and says it was long overdue since marijuana convictions follow someone throughout their life and make it hard for that person to get housing, find a job or get an education.

In a related development, the Oregon House also passed a bill granting the state governor authority to negotiate agreements with other states for the purpose of exporting Oregon’s excess marijuana as soon as the federal government tolerates or legalizes interstate marijuana commerce. This bill was passed on the same day (Tuesday, June 11) that the expungement bill was passed.

Supporters of Senate Bill 582 say that Oregon is being forward looking by passing enabling laws in preparation for federal reform of cannabis policies. Some even said that this bill isn’t an endorsement of the cannabis industry, but rather provides support for the business community since exporting marijuana would create more jobs and bring revenue into Oregon from the states with which it is trading.

It should be remembered that Oregon has a massive surplus of marijuana, and some people say about six years are needed to consume this excess if current demand levels are maintained.

However, opponents of SB 582 say that the bill is of no consequence since it is akin to hiring a financial advisor simply because you expect that you will soon win the lottery.

Analysts wonder what cannabis industry players like Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and ChineseInvestors.com Inc. (OTCQB: CIIX) have to say about the export bill passed by Oregon’s Senate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

At this year’s Cannabis Business Summit & Expo – the sixth such event hosted by the NCIA – discussion of the Secure and Fair Enforcement (SAFE) Banking Act is likely to be on the agenda, as well as many other critical issues that are currently affecting the cannabis industry. With its return to San Jose, the location of last year’s event, the nation’s most influential, award-winning cannabis conference and trade show continues to act as a catalyst for innovation in the space and pave the way for cannabis commerce.

The celebratory gathering, scheduled to take place from Monday, July 22, to Wednesday, July 24, at the San Jose McEnery Convention Center, will bring cannabis executives, investors and…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

According to a new policy which has just been made public by Transport Canada (the federal transport regulator), flight crews as well as other industry employees will no longer be allowed to use marijuana within 28 days before they are due to fly.

The policy, which was announced on Thursday (June 6), takes immediate effect and it affects cabin crew, pilots and air traffic controllers. This policy was released in order to clarify the position of the regulator when recreational marijuana was legalized on October 17 last year.

Transport Canada asserted that aviation industry employees are required to maintain a certain minimum “level of fitness for duty” during the time when they are at work. Those employees must therefore refrain from using or being under the influence of any substance which can impair their faculties to a degree that can compromise aviation safety, the regulator added. Transport Canada also affirmed that their policy decision was informed by the current science available on the matter.

The announcement by Transport Canada isn’t altogether new in the Canadian aviation industry. The policy announcement comes after commercial airlines in the country, such as Westjet and Air Canada, had already issued blanket bans to their staff regardless of whether the employees wanted to consume recreational marijuana when they are off duty.

Speaking about Westjet’s radical policy on marijuana, the airline’s spokesperson said that the policy reflects the airline’s position as a leader in aviation safety, and that was why they were requiring Westjetters to report for duty while fit and stay that way throughout their shift.

Transport Canada has chosen to take the path similar to what the Department of National Defence decided to take on recreational marijuana. The military rules were updated to state that any serving military officer who wishes to use recreational marijuana should not do so within eight hours of starting their shift on duty.

The military rules also state that any personnel who operate weapons or vehicles aren’t allowed to consume recreational pot 24-hours before reporting for duty. Those that engage in high-altitude parachuting and those who serve on military aircraft are banned from using recreational cannabis in the 28 days prior to reporting for duty.

The Royal Canadian Mounted Police also announced earlier that any of its personnel who serve in “safety-sensitive positions” are prohibited from using cannabis 28 days prior to reporting for duty.

It would be interesting to know what companies like Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) think about these policies announced by aviation companies and regulators.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The big pot stocks in Canada, such as Tilray Inc., Canopy Growth Corp. and Aurora Cannabis may soon have to contend with an emerging threat as marijuana growers in North America start moving their farms across the border to Columbia.

This migration is eerily similar to what happened to the growers of rose flowers who all moved south to low-cost Columbia.

Paul Henderson, the owner of Grupo Flor (a cannabis cultivation company based in Monterey) is the trailblazer of this migration. He predicts that North American marijuana growers in Canada will suffer the same fate that rose growers experienced. Practically no rose grower was left in Monerey once cultivation starting moving south.

Henderson adds that within the next decade, the cannabis industry will transition into a phase of commoditization. As that happens, it will become increasingly untenable to keep growing marijuana in Canada when Columbia is just a short distance away.

Henderson’s company is currently getting a 1,000,000 square-foot cultivation facility ready on the outskirts of Cali, a city found close to the Equator in Columbia. He boasts that when the facility starts operations, his company would be able to cut the price of its produce by 90 percent and still make a profit, something that growers who are still based in Canada cannot do and stay afloat.

Columbia enjoys several advantages which are only a dream to Canadian cannabis growers. First, the climate in Columbia is so good that the cultivation facilities there don’t require elaborate climate-control systems. Secondly, the labor in Columbia is highly skilled yet more affordable than what is available in Canada.

These reduced production costs put Columbia firmly on course to attain the target of producing a gram of cannabis at just 50 Canadian cents ($0.38) and yet the long-term goal of cannabis production in Canada is to bring the cost of a gram down to CAD $2 ($1.51) . That is a whole world of difference in production costs!

Columbia legalized medical cannabis for domestic use as well as export. This policy shift is responsible for the interest of Canadian cannabis growers in shifting their operations to Columbia.

The emergence of Columbia as a destination for Canadian cannabis cultivators has come at a time when the cannabis industry in Canada has just been dealt a blow by the U.S. FDA. The regulators are reluctant to legalize CBD and it appears to be headed for regulatory oversight by the FDA. This has dampened the hopes of Canadian firms that were gearing up to enter the U.S. CBD market.

Cannabis industry watchers are wondering what major players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International Inc. (NASDAQ: YGYI) can do to respond to developments like transferring marijuana cultivation facilities to another country different from the country where the company has its major operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Experiments with next-generation delivery systems appear certain to lead to better cannabis-based products.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has recently seen spectacular improvements in the effectiveness of cannabinoids thanks to its proprietary chemical delivery treatment. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF), which has won widespread praise for its innovative medical work, has seen good trial results for a new treatment for seizures.  Tilray Inc. (NASDAQ: TLRY) is supporting studies into the uses of cannabinoids to treat behavioral problems and HIV. MariMed Inc. (OTCQB: MRMD) has set up a subsidiary focused on CBD, currently the highest-profile cannabinoid product. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has established a new research lab to develop…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: Extraction technology plays a crucial part in the production of cannabidiol (CBD) from hemp.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a company already established in the hydroponic equipment business, is making plans to add extraction technology to its repertoire. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has been researching new medical applications for CBD and related chemicals — medicines for which extraction will be critical. KushCo Holdings Inc. (OTCQX: KSHB) has moved from providing support services to CBD-related companies to running its own store and has recently bolstered its leadership team for further growth. Harvest Health & Recreation Inc. (CSE: HARV) (OTCQX: HRVSF) has expanded swiftly over the past six years, growing from a single operation to a presence in five U.S. states. And in a boost to CBD’s public profile, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has teamed up with UFC to research the application of CBD and related treatments for…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

One of the biggest issues that has stood in the way of medical marijuana patients and healthcare professionals has been the challenge of how to determine the precise dosage to be administered in order to attain the required therapeutic effects. Additionally, it has been hard to find cannabis products whose potency is uniform in order to trigger repeatable outcomes in patients. To compound matters even further, CBD normally brings therapeutic effects at a certain specific concentration. Anything greater or lower than that optimum level reduces its efficacy. The marijuana industry has responded to these challenges by getting more clinical and scientific.

Stratos, a cannabis company based in Colorado, is one of those entities which have stepped up to provide medical cannabis products that are consistent in terms of potency. Their products are so precise that splitting a tablet in half is a guaranteed way to take just half of the dose indicated on the product label.

Charlotte Payton, the VP of Development and Co-founder of Stratos, revealed that the company leveraged the roots of its founders in the medical arena to find ways to bring the consistency which is a given in other industries to the medical cannabis space. She wondered why people would easily get reliability and consistency in pharmaceuticals but not cannabis. Strato’s solution addressed that issue.

GoFire is another healthcare technology company which is also blazing a trail in finding solutions to deliver consistency in the medical cannabis industry. One of the products which they have brought to market is called the GoFire Inhaler. The inhaler’s unique convection heating system, precision dosing mechanism and medical-grade materials and design have just been patented.

The inhaler made by GoFire was designed for medicines extracted from plants, so patients can use this product to take cannabis flower and concentrates. Buyers of the inhaler also get an app which allows them to track and document their dosage preferences in addition to connecting with a community of other users of the GoFire Inhaler.

The work of these two companies has been welcomed by both medical professionals and patients. One such professional who was full of praises for the inhaler is Denver-based Dr. Michael Keller. He said such devices help to ease some of the concerns that members of the medical community have about prescribing medical marijuana products. The possibility of recommending exactly how much a patient should consume at a given frequency brings medical marijuana closer to what is expected of any therapeutic product.

VPR Brands LP (OTC: VPRB) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) applaud the innovations introduced by Stratos and GoFire since these technologies will bring medical cannabis closer to becoming a mainstream way to treat or manage different health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Hope for Health, a Toronto-based charity, has been launched as the first cannabis charity registered by the Canadian government. The charity is registered in the category of organizations whose intention is the “advancement of education.”

Hope for Health says it aims to enable patients to manage their health effectively while also giving them the autonomy to choose which cannabis products and cannabis producers to deal with.

The charity kick-started its operations amidst fears that medical marijuana patients are getting reduced attention as more attention is directed towards the recreational market. This is seen in the rising medical marijuana product prices. Access points for medical cannabis are also reducing while a new excise tax on marijuana prices has also been imposed on medical marijuana products. This excise tax can only be waived on the product price if the company selling medical marijuana products opts to absorb that cost.

To alleviate this increased cost of medical marijuana products, Hope for Health has decided to avail a renewable monthly stipend to patients who meet the eligibility criteria of the charity. This stipend is conditioned upon the patient purchasing their medical marijuana products from one of the 170 producers licensed by the Canadian federal government.

Hope for Health intends to take on at least 150 patients during its first year of operation. More patients will be onboarded each year and the number will vary depending on the resources available as well as the level of interest displayed by patients.

The charity doesn’t only have its eyes on patients. Hope for Health plans to create and disseminate educational materials to health care professionals about the medicinal benefits of marijuana. This will be done in conjunction with creating partnerships with research organizations, academic institutions and medical associations.

Hope for Charity is the brainchild of Auxly Cannabis Group, an entity that provides financing to cannabis cultivators. Auxly Cannabis Group has committed itself to availing funding that they are calling “a cornerstone donation.” The funds will be used to get the charity on its feet.

Hugo Alves, the director of Hope for Health, remarked that the idea of the charity was conceived three years ago. The founders felt that every entity which had reaped from the cannabis industry in the country would rally around the idea and support its operations.

The founders also strongly felt that the leadership and management of the charity should be independent if Hope for Health is to retain its appeal to all players in the industry. To this end, they selected Dr. Jenna Valleriana as the Executive Director of the charity.

Dr. Valleriana is a respected cannabis policy expert who heads the National Institute for Cannabis Health and Education. She recently published a cannabis education toolkit which was used by two other organizations to design digital tools aimed at educating students and parents about marijuana.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) commend the people behind Hope for Health and wish them all the best in their noble undertaking.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

• Hemp seed genetics are critical to hemp farming success
• Cannabigerol (CBG) is emerging as a valuable cannabinoid with multiple potential health benefits
• Hemptown USA is growing one million rare cannabigerol-dominant plants designed to yield up to one million pounds of CBG biomass

High quality seeds are a key prerequisite for growing healthy, strong cannabis plants. The right seeds can deliver the right cannabinoid profile, increase resilience and help for achieving sufficiently sustainable yields.

Companies like Hemptown USA are pioneers in the farming of novel cannabinoid strains in addition to cannabidiol (CBD). In 2019, the company acquired $5.5 million worth of Oregon CBD Seeds, including one million rare…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

After the NFL announced that it was studying the possibility of using marijuana as a pain treatment for players, the NBA Commissioner Adam Silver has revealed that they too are considering the matter.

While the Commissioner was non-committal about when the rule changes would be made, he did admit that the matter was up for discussion with NBAPA (NBA Players Association).

Any changes to the marijuana rules of the NBA can only come as an inclusion in the collective bargaining agreement signed with the players association. However, the commissioner says that the players haven’t reached a consensus on the matter, so more discussions are needed to get everyone on board.

Commissioner Silver revealed that some players are concerned that if a teammate gets on the court while high on marijuana, such as player could let down the entire team by not giving the game their all.

Silver also said that in his opinion, there was nothing wrong with a player taking some cannabis as a way of winding down after a major game. To him, this is no different than taking a drink, and he feels that the NBA hasn’t moved with the times in permitting such social use of marijuana.

Silver is also open to looking into the medical uses, such as pain relief, of cannabis for NBA players. This is major attitude shift from the position he held two years ago when he told the press that he saw no need to amend the NBA policies to accommodate medical marijuana.

While the commissioner hasn’t made any firm commitments regarding reforming the cannabis policy of the league, the good news is that he is open to the possibility. However, any changes to be made are likely to take a few more years before coming into force since the current collective bargaining agreement with the association of players is still in force until the 2023/24 season comes to an end.

All the same, the fact that the NBA and other sports associations are looking into the potential benefits of marijuana is good news to advocates since such associations have always been notoriously conservative.

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) hope that the NFL updates its marijuana rules next year as is widely expected. This will open the way for other associations to follow this lead and update their own policies as well so that players enjoy the benefits of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Sherry Hoover, a retired nurse suffering from stage 4 cancer, has taken Michigan to court to challenge its newly imposed medical marijuana testing rules. The lawsuit filed in a federal court seeks to obtain a temporary restraining order so that the plaintiff can continue accessing her marijuana-derived medicine which has since become hard to obtain due to the new testing rules imposed by the state regulator.

The 57-year old plaintiff was diagnosed with mastocytosis leukemia in 2011. She used several prescription drugs, such as fentanyl patches and Norco, with limited effect until she discovered that medical marijuana could improve her appetite, alleviate her pain and enable her to sleep better.

Before April 1 this year, LARA (Licensing and Regulatory Affairs) permitted untested medical marijuana products to be sold in medical marijuana dispensaries. However, those untested tinctures, oils and other medicinal products made by registered caregivers would no longer be sold without being tested once the April 1 deadline passed.

The testing rules have since taken effect, and Hoover is finding it hard to access the products which have been instrumental in giving her a better quality of life. The lawsuit she filed on Wednesday (June 5) seeks to compel the state to extend the commencement of enforcing the testing rules to December 31.

She argues that the current restrictions have resulted in stock-outs in the only two licensed medical marijuana dispensaries which carried the products she uses. Continuing to enforce the testing rules may therefore leave her with no choice but to resort to the black market for her medicine, a step she doesn’t want to take.

The suit states that the four licensed testing facilities cannot cope with the demand for testing services from licensed cultivators, manufacturers and caregivers. Additionally, the added steps, such as transporting the untested products to the testing facilities and then hiring transport firms permitted to carry tested products to medical marijuana dispensaries prolongs the duration needed to get tinctures and other medical marijuana products made by caregivers to the dispensing points where patients can buy them.

In short, Hoover argues in her suit that the state is violating her rights of access to medical marijuana products and yet she is licensed and duly authorized to use such products.

This isn’t the first time that Sherry Hoover is suing the state. Last year, she successfully sued LARA to compel it to extend deadline imposed for unlicensed dispensaries to get the necessary permits or close by December 31, 2018. Her lawsuit was successful and the deadline was extended to April 1 this year.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) and Sugarmade Inc. (OTCQB: SGMD) long for the day when all the kinks in the way medical marijuana is regulated are fixed so that these seemingly endless deadline extensions and lawsuits in Michigan come to an end.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
As the hemp and CBD markets grow, a wide variety of CBD- and hemp-based products are becoming available, including products for pets.

Geyser Brands Inc. (TSX.V: GYSR) (GYSR Profile) has recently announced an acquisition that provides the company with two brands of hemp and CBD products. Indiva Ltd. (TSX.V: NDVA) (OTCQX: NDVAF), which provides infused products for humans, is working on a new extraction facility to increase its production. Viridium Pacific Group (TSX.V: VIR) (OTCQB: VIRFF) is supporting the growth of the hemp and cannabis industries through investment, both in acquisitions and in partnership with smaller companies. Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) has raised the public profile of CBD through celebrity associations and entry into prestige shops. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is producing CBD products for both humans and their furry companions.

To view the full editorial, visit http://cnw.fm/i5qlA

To hear the CannabisNewsAudio version, visit http://cnw.fm/X8smi

About Geyser Brands Inc.

Geyser Brands builds health-based, hemp-CBD consumer products in the nutraceutical, cosmetics, food-and-beverage and pet sectors worldwide. R&D investment in NanoFusion, a proprietary all-natural nanotechnology, delivers topical, cream, beverages and baked goods, oil, and tincture formulations with superior bioavailability and water solubility. Geyser Brands is a Health Canada-approved licensed producer (“LP”) in Port Coquitlam, British Columbia, that holds a cultivation license and is anticipating its processing and sales licenses. The company is exclusively focusing on leveraging these assets to provide the regulatory infrastructure for its global brands and distribution strategy, acquiring hemp- and plant-based brands and infusing them with new CBD product lines in jurisdictions where the therapeutic ingredient is legal. The company’s proprietary NanoFusion technology surrounds oils and solves for the insolubility of CBD. Geyser Brands will utilize its 7,000-square-foot licensed facility in British Columbia for the manufacturing and international distribution of its hemp- and CBD-based products. For more information, visit the company’s website at www.GeyserBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at  http://cnw.fm/GYSR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Franchising is one of the giant economic forces in the U.S. given the fact that this business model generated approximately $451 billion in 2018. Are we about to see cannabis enterprises built upon this model? Anyone intending to enter cannabis franchising needs to think about and find remedies to the following major bottlenecks.

Conflicts Between State and Federal Laws

Despite the legalization of marijuana for recreational or medical use in various states across the U.S., cannabis remains a Schedule 1 substance at the federal level. This creates major legal issues for businesses which wish to operate franchises in the cannabis industry. For example, a franchise owner cannot ship products across state lines in order to sell the excess products from one state in another state where supply is limited. This makes the possibility of prices nose-diving a real concern since gluts inevitably result in plummeting prices.

Tax Issues

According to the federal tax code, marijuana businesses aren’t eligible for any deductibles on the costs that they incur during the execution of their business activities. For example, marijuana businesses cannot deduct the cost of buying business premises and yet other enterprises which don’t transact in Schedule 1 substances can claim tax deductions on this business expense. These tax disadvantages mean that cannabis businesses will struggle to be profitable unless they can find ways to be super-efficient regarding non-deductible expenses.

Limited Consumer Awareness

Marijuana has been prohibited for long and certain stereotypes about the substance still exist even where prohibition has ended. Cannabis franchisees would therefore have to do a lot to educate their prospective customers in order to make sales on a consistent basis. This added challenge of performing customer education on an ongoing basis isn’t faced by franchises in other industries, such as the fast foods industry.

Limited Investor Interest

Currently, investors aren’t too eager to put their money in an industry which still faces legal uncertainties. This explains why US-based marijuana companies are generally undervalued when compared to their Canadian-based counterparts, for example. While this limited investor appeal exists, any cannabis franchisers that set up shop may struggle to attract investors unless the legal space changes for the better.

In the true entrepreneurial spirit, every challenge presents a business opportunity. The cannabis franchise space is therefore open for the taking for those individuals who devise ways to bring a franchise concept into the cannabis space in a way that ensures that investors will earn a return despite the challenges above. Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) hope that enterprising individuals will take up this challenge and devise franchises which will spur the growth of the cannabis industry even more.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A Congressional research body has released a report whose findings bring into question a common assumption which has always been made by legislators that the legalization of marijuana leads to more accidents on roads due to impairment.

The experts, who were instructed by Senate and Congress to study the issue of impaired driving, didn’t find any conclusive evidence that marijuana can cause a driver to be impaired.

While law enforcement agencies have tried and true tools to identify people who are driving while impaired by alcohol, developing similar tools for dealing with marijuana driving impairment has proved to be very challenging.

The problem isn’t just the lack of appropriate technology. Additional questions also exist regarding how much THC can cause impairment and how that impairment is caused. The CRS (Congressional Research Service) writes in its report that while laboratory tests have proved that one can be impaired after consuming marijuana, conflicting results were found when studies were done to ascertain the degree of added risk of fatal crashes resulting from marijuana consumption.

Both opponents and advocates of legalizing marijuana agree that a lasting solution should be found to the issue of how to detect marijuana-impaired driving. However, the experts still doubt whether it will be possible to develop appropriate technology to detect impaired driving since what is currently available can only test whether someone has recently consumed cannabis.

It is remarkable that the Congressional report mentions several times that it isn’t clear cut that marijuana consumption is associated with a heightened risk of traffic accidents. This runs counter to the assumption which has been commonly held by Congress that when marijuana restrictions are loosened, there will be a rise in traffic accident fatalities.

This line of thinking also appeared in the wording of a recent House Appropriations Committee report in which funds were allocated to law enforcement agencies to identify drivers impaired by marijuana as a way of reducing the fatal accidents resulting from the increasing legalization of marijuana by states around the country.

Different researchers have reported that fatalities on the road don’t increase after marijuana has been legalized by a state. However, this doesn’t alter the reality that both sides on the marijuana legalization issue advise against driving after one has consumed cannabis.

The deputy director of NORML explained how hard it is to determine impairment from marijuana. He says that the effects on the psychomotor system are normally less acute and take a shorter time if one consumes marijuana, unlike the opposite case after alcohol consumption. Furthermore, THC remains detectable for a longer time, so a positive test doesn’t prove that one is impaired or consumed cannabis recently.

The Congressional researchers offer a number of recommendations on what Congress can do in light of the information gathered by the researchers. One recommendation is that more research should be done to determine whether a quantitative standard is feasible when determining cannabis impairment.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4), Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) welcomes the report of the Congressional Research Service because it helps to dispel some of the misconceptions about marijuana use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]